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1 Summary
It is crucial for every cell of an organism to sense and repair defects that occur in its 
genetic material. Cells are constantly exposed to DNA-damaging agents  from exogenous 
and endogenous sources such as the Sun’s radiation or metabolically produced free 
oxygen radicals. The mechanisms to deal with DNA damage consist of repair systems as 
well as kinase-dependent signaling pathways (so-called DNA damage checkpoints) that 
delay or arrest cell cycle progression. The response to DNA damage also includes 
alteration of transcription and regulation of apoptosis. This  complex signaling network is 
referred to as the DNA damage response (DDR).
Of all types of DNA damage, DNA double strand breaks (DSBs) pose the greatest 
challenge to cells. If DSBs remain un-repaired or are repaired incorrectly, the genome can 
suffer translocations and deletions, which may ultimatively lead to genome instability and 
harmful diseases such as cancer. In response to DSBs, the MRE11/RAD50/NBS1 (MRN) 
complex acts as sensor and activates the proximal kinases ATM and DNA-PKcs. These 
kinases phosphorylate various  target proteins including the histone variant H2AX. MDC1 is 
an essential mediator/adaptor protein that directly binds to phosphorylated H2AX (γH2AX) 
through its  tandem BRCT domains. In addition, MDC1 is  necessary for the amplification of 
the signal and for establishing a chromatin environment that is proficient for efficient repair 
of DSBs. 
In this study, we describe the molecular mechanism of MDC1-mediated accumulation 
and retention of the MRN complex in chromatin regions flanking DSBs. MDC1 is 
constitutively phosphorylated at multiple conserved SDT motifs by Casein kinase 2 (CK2). 
The MRN accumulation is achieved through direct binding of the FHA and BRCT tandem 
domain of NBS1 to the phosphorylated SDT motifs of MDC1. Mutations in conserved amino 
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acids within the NBS1 FHA and BRCT domains, which are essential for the binding to the 
phospho-epitope, revealed that the accumulation of MRN in IRIF is  not required for the 
activation of the G2/M checkpoint response. Interestingly, while cells  containing a mutation 
in the BRCT domain of NBS1 had only a minor G2/M checkpoint defect, cells harboring a 
NBS1 mutated in its FHA domain showed a clear G2/M checkpoint defect at low doses of 
irradiation. These results suggest an additional function of the FHA domain of NBS1 in 
checkpoint signaling.
During the search for ATM-dependent phosphorylation sites in MDC1 we identified the 
Thr4 residue to be targeted in a DNA damage specific manner. Interestingly, this residue 
bound to the FHA domain of MDC1 itself leading to dimerization of the protein. This 
interaction was confirmed by isothermal titration calorimetry (ITC) and X-ray 
crystallography, revealing that the FHA domains of two MDC1 molecules associate in a 
head-to-tail orientation in a DNA damage-dependent manner. These findings add MDC1 to 
the growing list of mediator/adaptor proteins that show dimerization and/or oligomerization.
In summary, this work thus contributes substantially to our understanding of the 
mechanisms by which the mediator/adaptor protein MDC1 functions in the mammalian 
DDR.
Summary
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2 Zusammenfassung
Es ist von entscheidender Bedeutung für jede Zelle eines Organismus, Defekte im 
Genom zu erkennen und zu reparieren. Zellen sind andauernd Substanzen ausgesetzt, 
welche die DNS beschädigen. Diese können von der Umwelt (z.B. Sonnenstrahlung) oder 
durch den Organismus selbst (z.B. freie Sauerstoffradikale) produziert werden. Die 
Mechanismen, um auf solche DNS Schäden zu reagieren, bestehen aus Reparatur-
systemen sowie Kinase abhängigen Signalwegen (so genannte Kontrollpunkte), welche 
den Zellzyklus verzögern oder anhalten. Die zelluläre Antwort auf Schäden in der DNS 
beinhaltet ausserdem die Regulierung der Transkription und des programmierten Zelltodes 
(Apoptose).
Von allen Arten von Schäden der DNS stellt der Doppelstrangbruch die grösste Gefahr 
für eine Zelle dar. Wenn Doppelstrangbrüche nicht erkannt oder falsch repariert werden, 
kann das Genom durch Translokationen und Deletionen verändert werden. Diese 
Veränderungen können zu Instabilität des Genoms und zu gefährlichen Krankheiten (z.B. 
Krebs) führen. Der MRE11/RAD50/NBS1 (MRN) Komplex dient als  Sensor für die 
Erkennung von Doppelstrangbrüchen. Er aktiviert die Kinasen ATM und DNA-PKcs, welche 
verschiedene Proteine phosphorylieren, darunter auch die Histon Variante H2AX. MDC1 ist 
ein essenzielles  Adapterprotein, welches via seine BRCT Domänen direkt an 
phosphoryliertes H2AX bindet. Im Weiteren ermöglicht MDC1 die Rekrutierung von 
verschiedenen Proteinen, welche für die Reparatur und die Signalübertragung wichtig sind. 
Dadurch hilft MDC1 bei der Bildung einer Chromatinumgebung, welche die effiziente 
Reparatur von Doppelstrangbrüchen ermöglicht.
In dieser Arbeit beschreiben wir den molekularen Mechanismus, wie MDC1 den MRN 
Komplex bindet und zu Doppelstrangbrüchen rekrutiert. MDC1 wird in mehreren SDT 
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Motiven durch die Casein Kinase 2 konstitutiv phosphoryliert. Die Akkumulierung von MRN 
erfolgt durch die direkte Bindung der FHA und BRCT Domänen von NBS1 an die 
phosphorylierten SDT Motive von MDC1. Mutationen in konservierten Aminosäuren 
innerhalb der FHA und BRCT Domänen von NBS1 zeigten, dass die Bindung von MRN 
nicht für die Aktivierung des G2/M Kontrollpunktes verantwortlich ist. Interessanterweise 
hatten nur die Zellen mit einer Mutation in der FHA Domäne von NBS1 einen Defekt im G2/
M Kontrollpunkt, nicht aber die Zellen mit einer Mutation in der BRCT Domäne von NBS1. 
Diese Resultate deuten auf eine zusätzliche Funktion der FHA Domäne von NBS1 im 
Signalweg nach DNS Schäden hin.
Die Suche nach ATM abhängigen Phosphorylierungs-Stellen in MDC1 zeigte, dass die 
Aminosäure Thr4 als  Folge von DNS-Schäden phosphoryliert wird. Diese Aminosäure 
bindet an die FHA Domäne von MDC1, was zu einer Dimerisierung des Proteins führt. 
Diese Bindung konnte mit Hilfe von Isothermaler Titrations Kalorimetrie sowie 
Röntgenstrahl-Kristallographie bestätigt werden. Dabei stellten wir fest, dass  die FHA 
Domänen von zwei MDC1 Molekülen in umgekehrter Orientierung aneinander binden. 
Diese Resultate fügen MDC1 zur wachsenden Liste von Adapterproteinen hinzu, welche 
Dimere oder Oligomere bilden können.
Insgesamt trägt diese Arbeit substanziell zu unserem Verständnis der Mechanismen 
bei, wie das Adapterprotein MDC1 in der zellulären Antwort auf Schäden in der DNS wirkt.
Zusammenfassung
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3 Abbreviations
ATM Ataxia telangiectasia mutated
ATR Ataxia telangiectasia and Rad3 related
BRCA1 Breast cancer 1
BRCT BRCA1 C-terminal
CHK1/2 Checkpoint protein 1/2
CK2 Casein kinase 2
DDR DNA damage response
DNA-PKcs DNA-dependent protein kinase catalytic subunit
DSB DNA double strand break
FHA Forkhead-associated
GFP Green fluorescent protein
HR Homologous recombination
IR Ionizing radiation
IRIF Ionizing radiation induced foci
ITC Isothermal titration calorimetry
MDC1 Mediator of DNA damage checkpoint 1
MEF Mouse embryonic fibroblast
MRN MRE11-RAD50-NBS1
NBS Nijmegen breakage syndrome
NHEJ Non homologous end joining
NMR Nuclear magnetic resonance
PIKK Phosphoinositide-3-kinase-related protein kinase
PNK Polynucleotide kinase
PST Pro-Ser-Thr
RNF8 Ring finger protein 8
SCD SQ-TQ cluster domain
SDT Ser-Asp-Thr
TBB Tetrabromo-2-azabenzimidazole
  Abbreviations
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4 Introduction
4.1 General introduction
4.1.1 Importance of maintenance of genome stability for the cell in the context 
of cancer development
It is very crucial for the survival of each organism that the DNA, which carries the 
genetic information, is  accurately duplicated and transferred from each cell to its daughter 
cells. Moreover, the DNA has to be protected from mutations, which can cause a variety of 
diseases including cancer. As the genome is  under constant attack from DNA damaging 
agents, either generated within the cell or originating externally as chemicals or radiation, 
the surveillance and repair mechanisms that ensure genomic stability are of great 
importance for all organisms (Figure 1).
Many different types of DNA damages can occur, such as base damage, single-strand 
breaks, or bulky adduct formation on the DNA. Among the most dangerous lesions for a cell 
are DNA double-strand breaks (DSBs). Un-repaired DSBs can cause cell death and 
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Figure 1 Karyotypes of a normal human cell compared with that of a tumor 
cell. A normal human’s set of chromosomes contains pairs of 23 standard 
chromosomes (left), whereas a tumor cell exhibits the irregular karyotype (right) 
described as aneuploid: some whole chromosomes are missing, extra copies of 
others are present, and many have exchanged fragments. (from: 
www.physorg.com/news102179512.html; Peter Duesberg, UC Berkeley)
potential outcomes of incorrect repair are chromosomal rearrangements or unfaithful 
chromosome distribution to daughter cells, with both results being hallmarks  of cancer 
(Khanna and Jackson, 2001). Intrinsic DNA damaging agents  such as the metabolically 
produced reactive oxygen species primarily lead to the damage of single bases or to the 
formation of single-strand breaks. However, it is  generally believed that all of these lesions 
can lead to the formation of DSBs, for example when two single-strand breaks occur face to 
face in close proximity on both strands of the DNA double helix, or during unsuccessful 
repair of other lesions. In addition, DSBs can also arise when the replication fork 
encounters damaged DNA and collapses (Paulsen and Cimprich, 2007), or as programmed 
cellular mechanisms such as the generation of antibody diversity (during V(D)J 
recombination and class switch recombination) and meiotic recombination in the germ cells 
(Bassing and Alt, 2004).
The importance of efficient detection and accurate repair of DSBs is emphasized by the 
existence of several human diseases  with defects in these processes that often exhibit a 
predisposition towards cancer (O'Driscoll et al., 2004). Treatment of tumor tissue using 
irradiation or radiomimetic drugs to kill cancer cells is widely used in the clinics. Although 
the treatment is more and more optimized to hit only the cancerous tissue, side effects 
arising from irradiated healthy cells  can still not be excluded. Therefore, it is  very important 
to understand the mechanisms that are activated in the surrounding healthy tissue. This 
would help to predict and assess a patient’s response to radiotherapy, and to optimize the 
treatment. One major drawback for the use of radiotherapy to treat cancer is the fact that 
cancerous lesions can acquire radio-resistance (e.g. glioblastomas). Understanding these 
mechanisms may help to develop efficient methods to sensitize tumor tissues to radiation.
There is another direct link between DSB formation and cancer. The analysis of 
precancerous and cancerous lesions from human patients  showed formation of DSBs in the 
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absence of any exogenous damaging agent. These observations suggested that a 
deregulated cell cycle (e.g. through the expression of oncogenes such as ras and myc) 
might be sufficient to induce high numbers  of DSBs, even without inactivation of genes 
involved in DNA repair and cell cycle checkpoints (so-called caretaker genes). In particular, 
precancerous lesions showed several indications of DSB formation, such as 
phosphorylation of H2AX, ATM, CHK2, and p53. In cancer tissue indications for DSB 
formation was visible as well, but the DNA damage checkpoint pathway was compromised, 
most often by p53 mutations (Bartkova et al., 2005; DiTullio et al., 2002; Gorgoulis  et al., 
2005). By reviewing these findings, Halazonetis et al. proposed an oncogene-induced DNA 
damage model for cancer development (Halazonetis  et al., 2008). According to this model, 
p53 activation in precancerous lesions leads to apoptosis or senescence, thereby raising a 
barrier to tumor progression. The development into cancer is  achieved by impairment of the 
DNA damage response, most often by p53 mutations. This  implies that DSB-formation can 
serve as an early marker for the onset of cancer. It remains to be shown if this model holds 
true for all cancers and if (or to what extent) chromosomal instability drives malignant 
transformation.
4.1.2 The DNA damage response 
During the past decade, our understanding of the different signaling pathways that are 
activated after DNA damage has greatly improved. The whole reaction network to deal with 
such DNA lesions is  generally referred to as  the DNA damage response (DDR) (recently 
reviewed in (Harper and Elledge, 2007)). It has become clear that the central role of the 
DDR is to ensure accurate repair of DNA lesions, faithful completion of DNA replication and 
activation of programmed cell death (apoptosis) in the presence of high numbers of DNA 
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lesions. The first descriptions of 
the DDR included three main 
groups of proteins that together 
formed a complex signaling 
network (Rouse and Jackson, 
2002; Zhou and Elledge, 2000). 
Th e se n so r p ro te i n s a re 
characterized by their ability to 
bind to aberrant DNA structures 
and to activate a global DNA 
damage response. Recognition 
of aberrant DNA structures then activates transducer proteins (usually kinases) that 
transmit the signal to a variety of effector proteins. These effectors define the various 
outcomes of the DDR. Among the most important effector pathways are the regulation and 
coordination of the different repair mechanisms dealing with different types of DNA lesions. 
In addition, aberrant DNA structures such as DSBs or long stretches of single-stranded 
DNA activate cell cycle checkpoints  that delay cell cycle progression to allow sufficient time 
for the completion of the repair. Even failing of the repair pathways  does not necessarily 
result in potentially deleterious consequences for the organism, as cells with too much 
DNA damage usually undergo apoptosis. For all mechanisms, a specific subset of genes 
can be activated or repressed at the transcriptional level by the DDR (Figure 2).
Among the many factors participating in the DDR, two types of kinases  play a 
prominent role. First, there are three kinases related to phosphoinositide 3-kinases (PIKKs) 
namely ATM, ATR, and DNA-PKcs. These are the first kinases activated after DNA damage 
and therefore, they are usually referred to as proximal kinases. Second, two classical 
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Figure 2 Schematic representation of the DNA 
damage response. See text for details.
transducer kinases exist: CHK1 and CHK2. The various effector proteins are either targeted 
directly by the proximal kinases or by one or both of the transducer kinases. Moreover, a 
new group of proteins has recently emerged. These proteins do not have enzymatic activity 
but instead are composed of protein-protein interaction domains, which serve as  recruiting 
platforms for many proteins involved in DNA damage signaling and repair. Therefore, this 
group of proteins  acts as  molecular “matchmakers”, and they are generally referred to as 
mediators or adaptors.
4.1.3 Ionizing radiation induced nuclear foci formation
A hallmark feature of DSB induction in mammalian cells is the formation of so-called 
ionizing radiation-induced nuclear foci (IRIF). These nuclear foci can be observed by 
microscopy and are detectable within minutes after exposure of the cells to ionizing 
radiation (Fernandez-Capetillo et al., 2003). Maximal brightness  and size of IRIF is reached 
after about 30 minutes. As DSBs are repaired, the IRIF disappear. The major regulator of 
IRIF formation is  the histone H2A variant H2AX, which becomes phosphorylated on Ser139 
(termed γH2AX) (Rogakou et al., 1998). While ATR is the primary kinase that 
phosphorylates H2AX in response to replication stress and UV irradiation (Ward and Chen, 
2001; Ward et al., 2004), it has been shown that ATM phosphorylates H2AX in response to 
DSBs (Burma et al., 2001; Fernandez-Capetillo et al., 2002). In addition, γH2AX is not only 
present directly at the DNA lesion but spreads over large chromatin regions on both sides of 
the break. In cells that cannot form γH2AX because of mutations in the phospho-acceptor 
site, the recruitment of DDR factors to IRIF formation was severely compromised (Celeste 
et al., 2003a). In addition, mice lacking H2AX are radiosensitive, show male-specific 
infertility, growth retardation, and defects in immunoglobulin class-switch recombination 
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(Celeste et al., 2002). This  indicates that γH2AX defines an epigenetic signal at sites of 
DSBs that is recognized by one or several factors, which then promote IRIF formation.
Many proteins that are recruited to IRIF contain protein interaction domains that can 
specifically recognize phospho-epitopes on other proteins. The best-studied example is the 
forkhead-associated (FHA) domain, which interacts with proteins containing phosphorylated 
threonine residues (reviewed in (Durocher et al., 2000a)). Another phospho-interaction 
domain often observed in proteins that accumulate in IRIF is the tandem BRCT (BRCA1 
carboxyl-terminal) domain, which preferentially binds  phorsphorylated serine residues 
(Clapperton et al., 2004; Manke et al., 2003; Williams et al., 2004; Yu et al., 2003).
4.1.4 MDC1 – a key factor for chromatin retention of DDR factors
A few years ago, it was shown that the mediator protein MDC1 (mediator of DNA 
damage checkpoint 1) directly binds to γH2AX via its  tandem BRCT domains (Stucki et al., 
2005). In cells  where this  interaction is disrupted, recruitment of other DDR factors such as 
NBS1, 53BP1 and the phosphorylated form of ATM to sites of DNA damage is 
compromised (Lukas et al., 2004; Rodriguez et al., 2003; Stewart et al., 2003; Stucki et al., 
2005). The importance of the MDC1-γH2AX interaction was also revealed in MDC1 
deficient mice. They recapitulate many phenotypes of the H2AX deficient mice including 
growth retardation, male infertility, immune defects, chromosome instability, DNA repair 
defects  and radiation hypersensitivity (Lou et al., 2006). It is  important to mention that initial 
recruitment of NBS1, BRCA1, and 53BP1 is independent of H2AX (Celeste et al., 2003b) 
and MDC1 (Bekker-Jensen et al., 2005; Lou et al., 2006; Lukas et al., 2004), but efficient 
accumulation and sustained retention of these factors require H2AX and MDC1 (Celeste et 
al., 2002; Lou et al., 2006; Stewart et al., 2003; Stucki et al., 2005; Ward et al., 2003). The 
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adaptor protein MDC1 contains  several functional domains (Figure 3). Besides the C-
terminal tandem BRCT domain responsible for γH2AX binding, MDC1 contains  an FHA 
domain at its N-terminus and a prolin-serine-threonine (PST) rich cluster domain, which 
seems to be important for DNA repair by homologous recombination (Xie et al., 2007). In 
addition, the SQ-TQ cluster domain (SCD) of MDC1 is  important for DNA damage signaling 
by recruiting the RNF8 ubiquitin ligase into IRIF (Huen et al., 2007; Kolas et al., 2007; 
Mailand et al., 2007).
Recent advances in life cell microscopy of green fluorescent protein (GFP)-tagged 
protein dynamics together with a new technology to induce DSBs in a defined sub-nuclear 
volume made it possible to dissect the events that occur in the establishment of IRIF in a 
spatio-temporal manner. This technique uses cells  pre-sensitized with halogenated 
thymidine analogues in combination with a focused UV laser beam to generate DNA 
damage in a defined sub-nuclear volume (Lukas et al., 2003). GFP-tagged versions of the 
DDR proteins MDC1, NBS1, 53BP1, and BRCA1 revealed a fast accumulation of MDC1 
and NBS1 at sites of microlaser-induced DNA damage, followed by a second wave of 
protein recruitment including factors such as 53BP1 and BRCA1 (Bekker-Jensen et al., 
2006). It has also become clear that the accumulation and retention of a subset of these 
factors require the activity of the RNF8 ubiquitin ligase. RNF8 is  recruited to chromatin 
regions flanking DSBs by MDC1 in a mechanism that requires prior phosphorylation of 
MDC1 by ATM. Recruitment of RNF8 then leads to the ubiquitinylation of the histones H2A 
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Figure 3 Schematic representation of MDC1 and its functional 
domains. See text for details.
and H2AX and to the subsequent recruitment of another ubiquitin ligase, RNF168. RNF168 
amplifies the chromatin ubiquitinylation, which ultimately leads to the efficient IRIF formation 
by 53BP1 and BRCA1 (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang 
and Elledge, 2007).
Based on the findings on IRIF formation and the crucial role of γH2AX and MDC1 in 
this  process, the following model for the recognition of DNA DSBs was proposed (Stucki 
and Jackson, 2006). The initial sensor of a DSB is the MRN complex, which helps  to recruit 
and activate ATM kinase. ATM phosphorylates various target proteins including H2AX 
molecules that are located in close proximity to the break. In a second step, γH2AX is 
recognized and bound by MDC1. MDC1 acts as  an adaptor protein by binding more 
molecules of the MRN complex and thereby recruiting more ATM. This leads to a positive 
feedback loop and to the amplification of the phosphorylation signal over large chromatin 
regions. A recent publication refined this model by showing that the positive feedback loop 
does not regulate the spreading of γH2AX, but the density of γH2AX in chromatin flanking 
Introduction
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Figure 4 Model for the regulation of H2AX phosphorylation by MDC1. See 
text for details.
sites of DSBs. In addition, it was shown that although both ATM and DNA-PKcs generate 
γH2AX, only ATM promotes spreading of the signal to maximal distance and maintains 
γH2AX densities. MDC1 was not required for spreading of the signal over distal sequences 
but only for establishment and maintenance of high γH2AX densities near the DSB (Savic 
et al., 2009) (Figure 4).
4.2 The interaction between MDC1 and the MRN complex
4.2.1 The MRE11-RAD50-NBS1 complex
The MRE11-RAD50-NBS1 (MRN) complex is a highly conserved and essential protein 
complex involved in DSB repair, checkpoint signaling, DNA replication, meiotic 
recombination, telomere maintenance, and induction of apoptosis (Difilippantonio et al., 
2007; Stracker et al., 2007; Stracker et al., 2004). Each of the three components of the 
complex is vital for cell survival, as null mutations in any of the three genes (MRE11, 
RAD50, and NBS1) lead to embryonic lethality in mice (Luo et al., 1999; Xiao and Weaver, 
1997; Zhu et al., 2001). MRE11 is a structure specific nuclease and is  involved in the 5’ to 
3’ resection of DNA ends, an essential step required for both DSB repair by homologous 
recombination and activation of the ATR-CHK1 branch of the DNA damage checkpoint 
response (Jazayeri et al., 2006). The second component of the complex is the ATPase and 
adenylate kinase subunit RAD50, which is thought to facilitate, together with MRE11, the 
tethering of DNA molecules to promote repair (Bhaskara et al., 2007; Costanzo et al., 
2004). NBS1 has no catalytic activities and could be classified as an adaptor/mediator 
protein from its domain structure. It contains a FHA and a tandem BRCT domain at its N-
terminus and it was shown that the C-terminus of NBS1 interacts directly with ATM (Falck et 
al., 2005). NBS1 is  mutated in a human disease called Nijmegen breakage syndrome 
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(NBS), and cells from NBS patients show DNA repair and DNA damage signaling 
deficiencies, including radiosensitivity, chromosomal instability, and checkpoint defects 
(D'Amours and Jackson, 2002). In addition, a mouse model where the NBS1 gene was 
exchanged with hypomorphic mutant alleles recapitulated many features  of NBS in the 
mouse. Although these mice were viable, they displayed defects in development and 
checkpoint initiation, showed increased chromosomal aberrations, and attenuated ATM 
activity after a low dose of ionizing radiation (Difilippantonio et al., 2005; Difilippantonio et 
al., 2007). The MRN complex is  thought to be the major sensor for DSBs in mammalian 
cells. It has intrinsic DSB binding activity (de Jager et al., 2001), is rapidly recruited to 
DSBs, and is essential for efficient activation of the ATM kinase. Microscopic studies 
revealed that the MRN complex is distributed to different subcompartments at sites of DSBs 
(Bekker-Jensen et al., 2006; Lukas et al., 2004). Although a fraction of MRN interacts  with 
single-stranded DNA formed after enzymatic DSB resection, most of the MRN accumulates 
in IRIF marked by γH2AX.
4.2.2 The interaction between MRN and MDC1
Intensive investigation has been done on the function of the MRN complex at sites of 
DSBs. It has become clear, that the N-terminal region of NBS1, which contains the FHA and 
BRCT domain, is necessary for the retention of MRN on chromatin. The disruption of the 
FHA domain impairs IRIF formation of the entire MRN complex (Cerosaletti and 
Concannon, 2003; Zhao et al., 2002). In addition, reconstitution experiments of NBS cells 
revealed that the N-terminus of NBS1 is  important for survival, optimal ATM activity, and the 
intra-S-phase checkpoint after ionizing radiation (Cerosaletti and Concannon, 2004; 
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Cerosaletti et al., 2006; Cerosaletti and Concannon, 2003; Horejsi et al., 2004; Lee et al., 
2003a; Tauchi et al., 2001; Zhao et al., 2002).
Although it was known that the FHA domain of NBS1 is required for MRN IRIF 
formation, it remained unclear as to how the interaction with the DSB-flanking chromatin is 
established in detail. An earlier publication suggested that the NBS1-FHA domain interacts 
directly with γH2AX (Kobayashi et al., 2002). However, recent evidence suggests that the 
interaction between NBS1 and γH2AX is  not direct but mediated by MDC1. Most 
significantly, several independent studies revealed that siRNA-mediated knockdown of 
MDC1 in human cells  (Goldberg et al., 2003; Lukas et al., 2004; Stewart et al., 2003) or 
knock out of the MDC1 gene in mouse cells (Lou et al., 2006) prevented the accumulation 
of the MRN complex at sites  of DSBs. Consistent with this, kinetic measurements in living 
cells showed that NBS1 could not accumulate at DSB-flanking chromatin from the earliest 
time points  after DNA damage in the absence of MDC1, despite the fact that H2AX was 
efficiently phosphorylated in these regions (Lukas et al., 2004). Moreover, most of the 
MDC1 could be immunodepleted form cell lysates  with antibodies against the MRN core 
components, indicating that MDC1 interacts with the MRN complex in cell extracts  from 
undamaged cells (Goldberg et al., 2003). This holocomplex dissociates upon modification 
of the NBS1-FHA domain, suggesting that the N-terminus of NBS1 is important for the 
interaction between these two factors (Lukas et al., 2004). The observation that MDC1 and 
NBS1 were recruited with almost identical kinetics to laser-microirradiated stripes in the 
nucleus supported the model of constitutive MDC1-MRN complex formation. Another 
indication that the chromatin retention of MRN is mediated by MDC1 came from phospho-
peptide pull-down experiments with phosphopeptides derived from the H2AX C-terminus. 
The MRN complex interacted with these phospho-peptides  only in the presence of MDC1 
(Lukas et al., 2004). In addition, MDC1 was shown to bind to the phosphorylated C-
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terminus of H2AX with high specificity and the crystal structure of the MDC1 BRCT domains 
together with a γH2AX peptide was solved. This structure suggested that the BRCT 
domains of MDC1 are uniquely tailored to bind γH2AX (Stucki et al., 2005). Moreover, 
experimental disruption of the MDC1-γH2AX interaction abrogated the retention of the MRN 
complex at sites of DNA damage (Stucki et al., 2005). Collectively, these data support the 
model where MDC1 functions as a molecular matchmaker to induce sustained 
accumulation of the MRN complex within the DSB-flanking chromosomal region marked by 
γH2AX. However, the mechanism of MDC1-MRN complex formation remained elusive. In 
chapter 5.1 and 5.2 of this thesis, the mechanism by which MDC1 mediates MRN 
accumulation at sites of DSBs is revealed. Moreover, potential functional implication of 
MRN accumulation is discussed.
4.3 The FHA domain of MDC1 mediates MDC1 dimerization
4.3.1 Structure and binding characteristics of the FHA domains
The forkhead-associated (FHA) domain was discovered originally in forkhead family 
transcription factors (Hofmann and Bucher, 1995). So far it has  been identified in more than 
2000 proteins  (Pfam database) in prokaryotes and eukaryotes and it is  present in many 
regulatory proteins, kinases, phosphatases, and transcription factors (recently reviewed in 
(Mahajan et al., 2008)). Among all the different classes of phosphoprotein binding domains, 
the FHA domain is  the only one that specifically recognizes  phosphothreonine (pThr) 
residues. Other domains such as WW and 14-3-3 proteins recognize both pThr and 
phosphoserine (pSer) residues. FHA domains play important roles in many biological 
processes such as cell growth, signal transduction, and cell cycle regulation. In particular, 
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many proteins of the DDR contain FHA domains, as for example the human proteins 
MDC1, NBS1, RNF8, CHK2 and its yeast orthologue RAD53p.
To date, 16 structures of either free FHA domains, or FHA domains bound to their 
ligand peptides have been solved by nuclear magnetic resonance (NMR) or X-ray 
crystallography. Despite low sequence homology between the different FHA domains, they 
all have a similar fold. The FHA domain consists  of approximately 95 to 121 amino acids 
and contains 11 mandatory β-strands. They form two large β-sheets, which are folded into a 
β-sandwich structure. The major structural differences occur in the loops and turns that 
connect the β-strands, and these regions are responsible for the ligand-specificity of the 
different FHA domains (Figure 5).
Combinatorial peptide library approaches were previously used to identify the ligand 
specificity of different peptide interaction domains (Songyang et al., 1993; Yaffe and 
Smerdon, 2004). This method was also applied to identify FHA domain interaction motifs 
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Figure 5 Structure of the RAD53p FHA1 domain. Left: Ribbons representation of the 
RAD53p FHA1 domain. Right: In vitro-selected pThr-containing peptides bind at one end of 
the FHA domain, interacting with loops and turns between the β-strands (from: Yaffe and 
Smerdon, 2004).
using pThr, pSer, or pTyr peptide libraries with two or three randomized residues on each 
side. The first library screenings were done with the RAD53p-FHA1 domain, and two 
independent groups showed specificity towards peptides that contain an Asp at the +3 
position after the phosphoacceptor Thr residue (pTXXD) (Durocher et al., 2000b; Liao et al., 
2000). For the RAD53p-FHA2 domain, the results were less clear suggesting both pYXL 
(Wang et al., 2000) and pTXXL (Durocher et al., 2000b; Liao et al., 2000) as preferred 
recognition motifs. Overall, the results of different screenings led to the suggestion of the so 
called “pThr+3 rule” for FHA domains with the pThr and the residue at the pThr+3 position 
being the primary and secondary recognition sites, respectively. The preferred +3 residues 
usually came from two major categories: either Asp or Ile/Leu (Durocher et al., 2000b; Li et 
al., 2000). There are some exceptions to this rule, as the FHA domain of KAPP (kinase-
associated protein phosphatase) prefers Ser or Ala (Ding et al., 2007; Durocher et al., 
2000b), whereas the FHA domain of RNF8 (RING-finger protein 8) binds with a strong 
preference to peptides with Tyr or Phe at the +3 position (Huen et al., 2007).
In addition to this “pThr+3 rule” suggested by the library screenings, other biochemical 
approaches to identify binding partners of FHA domains revealed different binding 
specificities. Some FHA domains showed multiple pThr+3 specificities, as for example the 
FHA1 domain of RAD53 can bind to pTXXD as well as pTXXI sequences (Mahajan et al., 
2005). In addition, there are FHA domains that recognize residues  both N-terminal and C-
terminal to the pThr. This was shown for the interaction of the murine PNK-FHA domain 
complexed with a peptide derived from its biological target XRCC4, where only the residues 
N-terminal to pThr were essential for binding (Bernstein et al., 2005). Another example is 
the DUN1p-FHA domain that interacts  with the phosphorylated SQ-TQ cluster domain 
(SCD) of RAD53p. This  interaction leads to the activation of DUN1p (Lee et al., 2003b). 
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Finally, the FHA domain of KI67 recognizes an extended binding surface rather than a short 
phosphopeptide sequence (Byeon et al., 2005; Li et al., 2004).
4.3.2 FHA domains that mediate protein dimerization
The human checkpoint kinase 2 (CHK2) is  a tumor suppressor, and mutations in Chk2 
were identified in a subset of malignancy-prone Li-Fraumeni syndromes and in sporadic 
human cancer. CHK2 contains an N-terminal SQ-TQ cluster domain (SCD), an FHA 
domain, and the kinase domain. Together with CHK1, CHK2 plays a critical role in cell cycle 
regulation, DNA repair, and DNA damage induced apoptosis (Bartek et al., 2001). Upon 
DNA damage, CHK2 is phosphorylated by ATM and ATR at Thr68 in the SCD domain (Ahn 
et al., 2000). This  phospho-Thr residue is  bound by the FHA domain of other CHK2 
molecules, which leads to dimerization or oligomerization of the protein. In a second 
activation step CHK2 undergoes autophosphorylation at the kinase activation loop, and this 
is  necessary for the full activation of CHK2 (Ahn et al., 2002; Xu et al., 2002). In a more 
recent approach using expressed protein ligation to generate the N-terminal regulatory 
region of CHK2, Li et al. were able to show that the phosphorylation of Thr68 stabilized the 
weak FHA-FHA interactions  that occur in the absence of phosphorylation. This study 
proposed that the dimerization modulates potential phosphodependent interactions with 
effector proteins and substrates. Furthermore, a mechanism allowing the dissociation of the 
CHK2 dimer following kinase domain activation was proposed, since the phosphorylation of 
the FHA domain at Ser140 led to a release of the Thr68 binding (Li et al., 2008). Activated 
CHK2 phosphorylates various downstream targets, which leads to the activation of cell 
cycle checkpoints or apoptosis (Bartek et al., 2001).
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Similar two-step activation and dimerization mechanisms were also reported for the 
CHK2 orthologues in yeast: CDS1 in S.pombe and RAD53p in S.cerevisiae. Upon 
replication stress, CDS1-FHA domain binds to phosphorylated MRC1, which leads to the 
recruitment of CDS1 to the upstream kinase RAD3 and the phosphorylation of Thr11 of the 
CDS1-SCD (Tanaka et al., 2001; Tanaka and Russell, 2004). The CDS1-FHA domain then 
binds to pThr11, which leads to dimerization and autophosphorylation of CDS1 (Xu et al., 
2006). In the case of RAD53p, the mechanism of transactivation is less clear. RAD53p 
contains two FHA domains, FHA1 and FHA2, which may play diverse and overlapping roles 
in regulating RAD53p activation and binding to phosphorylated substrates (Pike et al., 
2003; Schwartz et al., 2003). In response to DNA damage and replication stress, RAD53p 
is  recruited by two adaptor proteins, RAD9 and MRC1, and phosphorylated by MEC1 
(Alcasabas et al., 2001; Osborn and Elledge, 2003; Sun et al., 1998; Sweeney et al., 2005). 
Following this initial phosphorylation, RAD53 forms dimers  or oligomers, which undergo 
autophosphorylation (Ma et al., 2006)
4.3.3 The FHA domain of MDC1
As mentioned above, MDC1 contains an FHA domain in its N-terminal region. The 
functional implication of this  domain is still not clear, although several interaction partners 
for the MDC1-FHA domain have been proposed. First, in vitro binding assays suggested 
that the MDC1-FHA domain binds to CHK2 phosphorylated at Thr68. In addition, MDC1 
colocalized with pThr68-CHK2 in immunofluorescence experiments (Lou et al., 2003). 
However, in another study, neither phosphorylated nor unphosphorylated CHK2 could be 
detected in microlaser-induced DSBs using fixed cells or in cells expressing a GFP-tagged 
version of the protein. When the recruitment of CHK2 to chromatin was forced by fusing 
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CHK2 to histone H2B, the DDR was severely compromised. This suggested that upon 
phosphorylation of CHK2 by ATM and subsequent activation, CHK2 is rapidly distributed 
throughout the nucleus to reach its  physiological targets  (Lukas et al., 2003). Second, pull 
down experiments using the MDC1-FHA domain efficiently retrieved MRE11 out of HeLa 
nuclear extract, indicating that the MDC1-FHA domain interacts with the MRN complex 
(Goldberg et al., 2003). Third, the phosphorylated form of the ATM kinase was suggested to 
bind to the MDC1-FHA domain as well (Lou et al., 2006). In addition to these attempts to 
identify binding partners for the MDC1-FHA domain, several functional studies were carried 
out using transient over-expression of the MDC1 FHA domain in cells  or using cell lines  that 
express an FHA deletion mutant of MDC1 (MDC1-ΔFHA). These studies revealed that 
over-expression of the FHA domain alone caused an attenuation of MDC1 recruitment and 
consequently also abrogated MRN foci formation after IR (Goldberg et al., 2003). Moreover, 
it was shown that cells expressing the MDC1-ΔFHA deletion mutant had defects in 
activation of checkpoints and apoptosis pathways, ATM recruitment, and repair of DSBs by 
homologous recombination (Goldberg et al., 2003; Lou et al., 2006; Lou et al., 2003; Xie et 
al., 2007).
In chapter 5.3 of this thesis, we provide biochemical, structural and cell biological 
evidence that the FHA domain of MDC1 regulates DNA damage-induced MDC1 
dimerization in a mechanism that is reminiscent of the CHK2 dimerization.
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5 Results
5.1 Constitutive phosphorylation of MDC1 physically links the MRE11-
RAD50-NBS1 complex to damaged chromatin
J Cell Biol, 2008, Vol 181, Pages 227-240
My contribution to this work was:
• Discovery of the mechanism of the interaction between MDC1 and MRN
• Design of the experiments (together with M. Stucki)
• Generation of most of the reagents
• Gathering most of the data (except Fig. 4A and 5)
• Proofreading of the manuscript
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 Introduction 
 Eukaryotic cells are equipped with sophisticated mechanisms to de-
tect, signal the presence of, and repair DNA damage. Of particular 
importance are the pathways that deal with DNA double-strand 
breaks (DSBs): highly toxic lesions that, if unrepaired or repaired 
incorrectly, can cause cell death, mutations, and chromosomal trans-
locations and can lead to diseases such as cancer. Cells react to 
DSBs by rapidly deploying a host of proteins to the damaged chro-
matin regions. Some of these factors engage in DNA repair, whereas 
others trigger a signaling pathway (called the DNA damage check-
point) that provokes delays in cell cycle progression and coordinates 
the repair process; together, these events comprise the so-called 
DNA damage response (DDR;  Zhou and Elledge, 2000 ). 
 Among the ! rst proteins that accumulate at sites of DSBs 
in eukaryotic cells is the MRE11 – RAD50 – Nijmegen breakage 
syndrome 1 (NBS1 [MRN]) complex, a conserved and essential 
DDR factor that functions in a multitude of cellular processes in-
volving DSBs, including DSB repair, checkpoint signaling, DNA 
replication, meiotic recombination, and induction of apopto-
sis ( Stracker et al., 2004, 2007 ;  Di! lippantonio et al., 2007 ). 
The MRN complex consists of three subunits. The ! rst is the 
structure-speci! c nuclease MRE11, which is most likely involved 
in nucleolytic processing of DNA ends to allow homologous re-
combination repair ( Jazayeri et al., 2006 ), and the second is the 
ATPase and adenylate kinase subunit RAD50, which, together 
with MRE11, appears to facilitate tethering of DNA molecules 
to promote DSB repair ( Costanzo et al., 2004 ;  Bhaskara et al., 
2007 ). The third subunit of the MRN complex, NBS1, does not 
exhibit any catalytic activities. Instead, its domain composition 
suggests that it belongs to the family of adaptor/mediator pro-
teins of the DDR, a group of recently emerging factors that inte-
grate, coordinate, and enhance the various cellular responses 
to DNA damage by promoting protein – protein interactions 
( D ’ Amours and Jackson, 2002 ). Consistent with this notion, 
NBS1 features both forkhead-associated (FHA) and BRCA1 
C-terminal (BRCT) domains at its N terminus, which are protein 
interaction modules that speci! cally mediate the interaction with 
The MRE11 – RAD50 – Nijmegen breakage syndrome 1 (NBS1 [MRN]) complex accumulates at sites of DNA double-strand breaks (DSBs) in microscopically dis-
cernible nuclear foci. Focus formation by the MRN com-
plex is dependent on MDC1, a large nuclear protein that 
directly interacts with phosphorylated H2AX. In this study, 
we identifi ed a region in MDC1 that is essential for the focal 
accumulation of the MRN complex at sites of DNA damage. 
This region contains multiple conserved acidic sequence 
motifs that are constitutively phosphorylated in vivo. 
We show that these motifs are effi ciently phosphorylated 
by caseine kinase 2 (CK2) in vitro and directly interact 
with the N-terminal forkhead-associated domain of NBS1 
in a phosphorylation-dependent manner. Mutation of these 
conserved motifs in MDC1 or depletion of CK2 by small 
interfering RNA disrupts the interaction between MDC1 
and NBS1 and abrogates accumulation of the MRN com-
plex at sites of DNA DSBs in vivo. Thus, our data reveal 
the mechanism by which MDC1 physically couples the 
MRN complex to damaged chromatin.
 Constitutive phosphorylation of MDC1 physically 
links the MRE11 – RAD50 – NBS1 complex to 
damaged chromatin 
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acting BRCT tandem domain at the C terminus, MDC1 also fea-
tures a unique repeat region in the middle of the protein (Pro-Ser-Thr 
[PST] repeat) and contains several highly conserved putative PIKK 
target sites, some of which are phosphorylated in response to DNA 
damage in vivo ( Matsuoka et al., 2007 ). In addition, MDC1 is also 
phosphorylated in the absence of DNA damage: several recent 
large-scale phosphorylation site screens of the human and mouse 
proteome revealed that MDC1 is constitutively phosphorylated on 
a signi! cant number of Ser and Thr residues in vivo ( Beausoleil 
et al., 2004 ;  Olsen et al., 2006 ;  Villen et al., 2007 ). 
 Although it is well established that MDC1 mediates the ac-
cumulation of many DDR factors in damaged chromatin regions 
(including the MRN complex, 53BP1, BRCA1, and ATM;  Stucki 
and Jackson, 2006 ), it is still unclear how MDC1 mediates MRN 
recruitment. The observation that MDC1 exists in a complex with 
MRN in extracts from undamaged cells suggests that MDC1 may 
recruit MRN to  ! -H2AX – containing chromatin in a simple  “ pig-
gyback ride ” mechanism whereby the physical interface between 
the two factors is made up by the NBS1 N-terminal FHA/BRCT 
region and by one or several phosphoepitopes on MDC1. 
 To put such a mechanism to the test, we set up an in vivo 
complementation system for MDC1 to search for a region in 
MDC1 that is responsible to mediate MRN foci formation. 
Through this approach, we identi! ed a new region in MDC1 
that is composed of several acidic repeats featuring a unique se-
quence motif, the Ser-Asp-Thr (SDT) motif. Furthermore, we 
provide evidence that these SDT repeats are constitutively phos-
phorylated by caseine kinase 2 (CK2) and that the phosphory-
lated form of these motifs constitute the phosphoepitope that 
the NBS1 FHA domain is binding to. These ! ndings allow us to 
draw a model of the mechanism by which MDC1 physically 
links the MRN complex to damaged chromatin. 
 Results 
 An acidic region near the N terminus of 
MDC1 is essential for NBS1 foci formation 
 Ef! cient accumulation of the MRN complex in foci at sites of 
DSBs is critically dependent on MDC1 ( Goldberg et al., 2003 ; 
 Lukas et al., 2004 ). To determine the region of MDC1 that medi-
ates MRN foci formation, we transfected MDC1  – / –  mouse em-
bryonic ! broblasts (MEFs;  Lou et al., 2006 ) with a series of 
N-terminal deletion mutants of mouse MDC1 and assessed MRN 
accumulation by indirect immuno" uorescence using an antibody 
speci! c for mouse NBS1 ( Celeste et al., 2003 ). Consistent with 
published data ( Lou et al., 2006 ), MDC1  – / –  MEFs were com-
pletely defective for NBS1 accumulation (unpublished data), but 
transient transfection of these cells with HA-tagged full-length 
mouse MDC1 readily restored NBS1 foci formation in response 
to 5 Gy of ionizing radiation (IR;  Fig. 1 B , WT). Deletion of 153 
and 295 N-terminal amino acids of MDC1 did not result in any 
detectable reduction of NBS1 foci ( Fig. 1 B ,  " N1 and  " N2), but 
deletion of 452 and 645 amino acids led to a complete loss of 
NBS1 accumulation ( Fig. 1 B ,  " N3 and  " N4). This indicated that 
the region in MDC1 essential for mediating NBS1 accumulation is 
located somewhere between amino acids 295 and 452. Indeed, inter-
nal deletion of this 157 – amino acid region completely abolished 
phosphorylated proteins ( Durocher and Jackson, 2002 ;  Glover 
et al., 2004 ). Moreover, several NBS1 interaction partners have 
been described; most prominent among these is the ataxia telan-
giectasia mutated (ATM) kinase, the key upstream component of 
DSB signaling ( Falck et al., 2005 ). Mutations in the  NBS1 gene 
leads to NBS in humans, and cells derived from NBS patients 
display a DSB repair and signaling de! ciency, including radio-
sensitivity, chromosomal instability, and checkpoint defects 
( D ’ Amours and Jackson, 2002 ). Mouse models in which the 
native mouse  NBS1 allele was exchanged with hypomorphic 
mutant alleles recapitulate many features of NBS in the mouse, 
including developmental defects, chromosomal instability, and 
checkpoint de! ciency ( Di! lippantonio et al., 2005 , 2007 ). 
 Accumulation of the MRN complex at sites of DSBs is mani-
fested by the formation of microscopically discernible subnuclear 
structures, so-called nuclear foci that represent large chromatin re-
gions containing one or several unrepaired DSBs ( Maser et al., 
1997 ). The key regulator of nuclear foci formation in higher eu-
karyotes is the histone variant H2AX, an integral component of the 
nucleosome core structure that comprises 10 – 15% of total cellular 
H2A in higher organisms ( Fernandez-Capetillo et al., 2004 ). H2AX 
is phosphorylated extensively on a conserved Ser residue at its 
C terminus in chromatin regions bearing DSBs, and this is mediated 
mainly by the ATM kinase, a member of the phosphoinositide-3-
kinase – related protein kinase (PIKK) family ( Burma et al., 2001 ). 
 Although it has been previously suggested that MRN accu-
mulation at sites of DSBs occurs through interaction between 
the FHA/BRCT region of NBS1 and phosphorylated H2AX 
( ! -H2AX;  Kobayashi et al., 2002 ), recent evidence suggests that 
the interaction between NBS1 and  ! -H2AX is not direct but is me-
diated by MDC1, a large nuclear factor that interacts with the MRN 
complex and also features the criteria of a DDR mediator/adaptor 
protein, including the presence of FHA and BRCT domains (for 
review see  Stucki and Jackson, 2004 ). First, it was shown that 
MDC1 exists in a complex with MRN in extracts of undamaged 
cells ( Goldberg et al., 2003 ). This complex dissociates upon modi-
! cation of the N-terminal FHA domain of NBS1, suggesting that 
the NBS1 FHA domain may be participating in the interaction be-
tween the two factors ( Lukas et al., 2004 ). Second, MDC1 directly 
and speci! cally interacts with the phosphorylated H2AX C ter-
minus through its tandem BRCT domains ( Stucki et al., 2005 ). 
The x-ray structure of the MDC1 – ! -H2AX complex suggests that 
the MDC1 BRCT domains are uniquely tailored to interact with the 
 ! -H2AX chromatin mark ( Stucki et al., 2005 ). Third, a phospho-
peptide derived from the H2AX C terminus interacted with the 
MRN complex only in the presence of MDC1 ( Lukas et al., 2004 ). 
Fourth, experimental disruption of the interaction between MDC1 
and  ! -H2AX ( Stucki et al., 2005 ) or loss of MDC1 expression by 
genetic manipulation and/or siRNA-mediated depletion leads to a 
complete abrogation of MRN foci formation ( Goldberg et al., 
2003 ;  Stewart et al., 2003 ;  Lukas et al., 2004 ;  Lou et al., 2006 ). 
Finally, mutations in the N-terminal FHA/BRCT region of NBS1 
also interfere with MRN accumulation at sites of DSBs ( Kobayashi 
et al., 2002 ;  Zhao et al., 2002 ;  Cerosaletti and Concannon, 2003 ; 
 Lee et al., 2003 ;  Horejsi et al., 2004 ). 
 MDC1 is composed of several distinct sequence domains. 
Besides an FHA domain at its N terminus and the  ! -H2AX – inter-
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A single amino acid (typically Asp) sits in between the highly 
conserved Ser and Thr residues. Thus, we hereafter refer to this 
motif as the SDT motif. The motif also contains two to three con-
secutive acidic amino acids (usually Glu) that are ! ve residues 
C terminal to the initial Ser. Mammalian MDC1 contains a total 
of six SDT motifs (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200709008/DC1): ! ve are located within the re-
gion of MDC1, whose deletion abrogates MRN foci ( Fig. 2 A ), 
and one is located  ! 80 amino acids N terminal to this region 
(not depicted). Zebra! sh MDC1 features a total of eight SDT 
motifs, and even honey bee MDC1 (the only clear nonvertebrate 
MDC1 orthologue identi! ed to date) comprises a very similar 
motif (Fig. S1), indicating that the SDT motif is conserved in all 
known MDC1 orthologues. 
 In untreated mammalian cells, MDC1 is a phosphoprotein 
that becomes rapidly hyperphosphorylated in response to DNA 
damage in a PIKK-dependent manner ( Goldberg et al., 2003 ; 
 Stewart et al., 2003 ). A large number of constitutive and DNA 
damage – induced phosphorylation sites have recently been iden-
ti! ed in MDC1 by means of several large-scale mass spectrom-
etry screens of the human and mouse proteome ( Beausoleil 
et al., 2004 ;  Olsen et al., 2006 ;  Matsuoka et al., 2007; Villen et al., 
2007 ). Interestingly, many of the constitutive phosphorylation 
sites of MDC1 are located within the SDT motifs ( Fig. 2 A ). 
In summary, it appears that in human cells, a population of MDC1 
molecules is phosphorylated on any Ser and Thr residue in at 
least four of the six SDT motifs in vivo ( Beausoleil et al., 2004 ; 
 Olsen et al., 2006 ). In addition, mouse MDC1 appears to be 
phosphorylated in at least one SDT motif ( Villen et al., 2007 ). 
the ability of MDC1 to mediate NBS1 foci formation ( Fig. 1 B , 
 ! I1). Preliminary sequence analysis of this region revealed a 
signi! cant abundance of acidic amino acids as compared with 
other regions of MDC1 ( Fig. 2 A). 
 Interestingly, deletion of a region between amino acids 
51 and 107 of mouse MDC1 (containing the FHA domain) 
did not have any effect on NBS1 accumulation ( Fig. 1 ,  ! I2) 
even though overexpression of the FHA domain was reported 
to trigger a dominant-negative effect on NBS1 foci forma-
tion ( Goldberg et al., 2003 ). In summary, these results sug-
gest that an acidic region near the N terminus of MDC1 
mediates MRN accumulation at sites of DSBs. 
 Phosphorylation-dependent interaction 
between the MDC1 N terminus and the 
MRN complex 
 To understand how the region identi! ed by the systematic dele-
tion analysis mediates MRN foci formation, we carefully ana-
lyzed the sequence between amino acids 295 and 452 of mouse 
MDC1. As mentioned in the previous section, this region of MDC1 
is highly acidic with a calculated isoelectric point of 4.04. 
To detect conserved sequence motifs within this region, we com-
pared the mouse sequence to MDC1 sequences from other ver-
tebrate species (including human, dog, swine, and zebra! sh). 
This analysis revealed several conserved patches of 8 – 10 amino 
acids interspersed with less conserved regions of variable length 
( Fig. 2 A ; patches are highlighted by horizontal bars). The con-
served patches feature a repeated sequence motif: Ser and 
Thr residues are embedded in an acidic sequence environment. 
 Figure 1.  An acidic domain near the N terminus of MDC1 is essential for NBS1 foci formation. (A) Schematic representation of HA-tagged full-length mouse MDC1 
and various deletion mutants. (B) MDC1  – / –  MEFs were transiently transfected with wild-type (WT) MDC1 and the individual deletion constructs. 48 h later, cells were 
irradiated, fi xed with methanol, and stained with antibodies specifi c for HA and mouse NBS1. Nuclear foci were assessed by confocal microscopy. Bar, 10  µ m. 
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 Figure 2.  Phosphorylation-dependent interaction between the MDC1 N terminus and the MRN complex. (A) Sequence alignment of the region in MDC1 
that is essential for MRN foci. The conserved acidic motifs are highlighted by horizontal bars. Phosphorylated residues identifi ed by in vivo phosphorylation 
site mapping are highlighted by arrowheads ( Beausoleil et al., 2004 ;  Olsen et al., 2006 ;  Villen et al., 2007 ). (B, top) Representation of human MDC1 and 
the overlapping GST fragments. (bottom) Two fragments at the N terminus of MDC1 are phosphorylated by CK2 in vitro. Purifi ed GST-MDC1 fragments 
were incubated with purifi ed recombinant CK2 in the presence of radioactive ATP. Proteins were separated by SDS-PAGE, and dried gels were subjected to 
autoradiography. A Coomassie blue – stained gel of the purifi ed GST fragments is shown on top of the autoradiograph. Note that fragment M-6 (PST repeat 
region) was not expressed in bacteria. (C) Purifi ed GST-MDC1 fragments (M-1 – 5) were preincubated with and without recombinant CK2 in the presence of 
ATP. (D) Purifi ed GST-MDC1 fragment M-3 was preincubated with CK2 either in the presence or absence of the CK2 inhibitor TBB. (C and D) The fragments 
were then used to pull down proteins from HeLa nuclear extract. Bound proteins were separated on SDS-polyacrylamide gels followed by immunoblotting. 
The blots were probed with antibodies against RAD50, NBS1, and MRE11. 
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 The acidic nature of the SDT motif suggests that it may be 
targeted by acidophilic kinases such as CK1 and 2. Indeed, ana ly -
sis of the MDC1 SDT domain by Scansite ( Yaffe et al., 2001 ) 
revealed that the sequence encompassing the Ser and Thr 
residues within the SDT motifs conform to consensus CK2 
phosphorylation sites. To test whether CK2 would speci! cally 
phosphorylate MDC1 in the SDT region, we generated eight 
overlapping random fragments of the human MDC1 cDNA and 
expressed them in  Escherichia coli as GST fusion proteins. Seven 
fragments were expressed well and were puri! ed ( Fig. 2 B , top), 
whereas one fragment (M-6) comprising the MDC1 PST repeat 
region was not expressed in bacteria. The puri! ed fragments 
were subjected to an in vitro kinase assay using recombinant CK2. 
CK2 ef! ciently phosphorylated fragment M-2 (amino acids 
109 – 330) and M-3 (amino acids 301 – 560) but none of the other 
! ve fragments. Fragment M-2 contains two SDT motifs, and 
fragment M-3 contains the other four SDT motifs. 
 MDC1 exists in a complex with MRN in extracts derived 
from undamaged cells, indicating that these proteins interact con-
stitutively (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200709008/DC1). However, the mechanism of this 
 interaction has not yet been elucidated. Signi! cantly, GST pull-
down analysis with our GST-MDC1 fragments revealed that 
fragment M-2 and M-3 only pulled down signi! cant quantities 
of the MRN complex from HeLa nuclear extract when pre-
incubated with recombinant CK2 and ATP ( Fig. 2 C , compare lanes 
 Figure 3.  Direct interaction between the 
phosphorylated MDC1 N terminus and the 
MRN complex is mediated by the NBS1 FHA 
domain. (A) MRN proteins were purifi ed as 
described in Materials and methods. Proteins 
were separated on SDS-polyacrylamide gels 
and stained with silver. MR, MRE11 – RAD50 sub-
complex; N, partially purifi ed NBS1. (B and C) 
Purifi ed GST-MDC1 fragment M-3 comprising 
part of the SDT region was preincubated with 
CK2 and ATP. The fragment was incubated 
with purifi ed MRN complex (B), purifi ed MR 
subcomplex (C, top), and partially purifi ed 
NBS1 (C, bottom) followed by GST pull-down 
analysis. Bound proteins were separated on 
SDS-polyacrylamide gels followed by immuno-
blotting. The blots were probed with antibodies 
against RAD50, NBS1, and MRE11. (D, top) 
Schematic representation of NBS1 with its func-
tional domains. (bottom) Purifi ed GST-MDC1 
fragment M-3 was preincubated with CK2 and 
ATP. The fragment was incubated with purifi ed 
MRN complex where the NBS1 subunit was 
either wild type or contained a point mutation 
in the FHA domain (R28A). Bound proteins were 
separated on SDS-polyacrylamide gels followed 
by immunoblotting. The blots were probed with 
a polyclonal antibody against NBS1. 
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 Figure 4.  A repeated phosphorylated motif in MDC1 mediates the interaction between MDC1 and NBS1.  (A) In vitro mapping of the CK2 phosphorylation 
sites in MDC1. (top) Sequence of the human MDC1 fragment comprising the conserved CK2 consensus sites (highlighted in black). The CK2 consensus sites 
are numbered from 1 to 10. (bottom) All of the putative CK2 phosphoacceptor Ser and Thr residues in the above MDC1 fragment (amino acids 141 – 621) 
were mutated to Ala, and the mutants were expressed as GST fusion proteins in  E. coli . The GST fragments were incubated with purifi ed recombinant 
CK2 in the presence of radioactive ATP. Proteins were separated by SDS-PAGE, and dried gels were subjected to autoradiography. A, autoradiograph; 
C, Coomassie blue – stained gel. (B) The SDT repeats are essential for the interaction between MDC1 and NBS1 in vitro. Several SDT motifs in a frag-
ment derived from mouse MDC1 (amino acids 221 – 456) were mutated to SDA (3T > A: T362A, T387A, and T444A; 4T > A: T315A, T362A, T387A, 
and T444A; 5T > A: T300A, T315A, T362A, T387A, and T444A; 6T > A: T222A, T300A, T315A, T362A, T387A, and T444A) and were expressed as 
GST fusion proteins in  E. coli . The purifi ed fragments were preincubated with recombinant CK2 in the presence of ATP. The fragments were then used to 
pull down proteins from HeLa nuclear extract. Bound proteins were separated on SDS-polyacrylamide gels followed by immunoblotting. The blots were 
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with the phosphorylated M-3 fragment of MDC1 and mediates 
the interaction between MDC1 and the MRN complex. 
 NBS1 features two well-established phosphopeptide rec-
ognition modules at its N terminus: an FHA domain and a tan-
dem BRCT domain ( Fig. 3 D , top). It was previously shown that 
introduction of a point mutation in the FHA domain that changes 
a conserved Arg residue to Ala (R28A) disrupted the interaction 
between MDC1 and the MRN complex in vitro ( Lukas et al., 
2004 ) and abolished MRN accumulation at sites of DSBs in vivo 
( Cerosaletti and Concannon, 2003 ;  Lee et al., 2003 ;  Horejsi 
et al., 2004 ;  Lukas et al., 2004 ). Thus, we isolated the MRN 
complex harboring the same mutation in NBS1 from baculovirus-
infected Sf9 cells and compared its binding activity toward the 
phosphorylated M-3 fragment to the wild-type complex. Signi! -
cantly, although the wild-type NBS1 readily interacted with 
phosphorylated M-3, no interaction was detected with the R28A 
mutant ( Fig. 3 D ). This indicates that an intact NBS1 FHA do-
main is essential for the interaction between the phosphorylated 
N-terminal region of MDC1 and the MRN complex. 
 A repeated phosphorylated motif in MDC1 
mediates the interaction between MDC1 
and NBS1 
 To map the phosphorylation sites within fragments M-2 and M-3 
of MDC1, we isolated a new GST fragment comprising amino 
acids 141 – 621 of human MDC1 (M-SDT). The puri! ed frag-
ment was phosphorylated in vitro by recombinant CK2 followed 
by digestion with trypsin. The tryptic peptides were then ana-
lyzed by mass spectrometry. Thus, several phosphorylation sites 
were mapped ( Table I ), most notably all six of the conserved 
SDT motifs that were targeted by CK2 on both Ser and Thr resi-
dues. Next, all of the putative CK2 target Ser and Thr residues in 
the M-SDT fragment were mutated to Ala and expressed in  E. 
coli ( Fig. 4 A , top; the SDT motifs and other putative CK2 target 
sites are highlighted in black and numbered from 1 – 10). The pu-
ri! ed mutants were subjected to in vitro phosphorylation by re-
3 and 4 with lanes 8 and 9; note that the bands in lanes 5 and 10 
in the top panel result from a cross-reactivity of the RAD50 an-
tibody with a contaminating bacterial protein in the GST – M-4 
fraction). In the absence of CK2, no interaction could be ob-
served under these conditions ( Fig. 2 C , lanes 2 – 6). In the pres-
ence of the speci! c CK2 inhibitor tetrabromo-2-azabenzimidazole 
(TBB), recombinant CK2 did not transform fragment M-3 into 
a form capable of pulling down the MRN complex from HeLa 
nuclear extract, indicating that CK2 activity is required for this 
process ( Fig. 2 D ). Together, these data suggest that the phos-
phorylated N-terminal region in MDC1 mediates the interaction 
with the MRN complex in vitro. 
 Direct interaction between the 
phosphorylated MDC1 N terminus and 
the MRN complex is mediated by the 
NBS1 FHA domain 
 To determine whether the MRN complex interacts directly with 
the phosphorylated MDC1 N terminus, we coexpressed all three 
MRN subunits and a subcomplex consisting of MRE11 and 
RAD50 (MR) in Sf9 cells by means of recombinant baculovirus 
infection followed by puri! cation of the recombinant proteins to 
near homogeneity ( Fig. 3 A , MRN and MR). We also isolated 
partially puri! ed NBS1 alone ( Fig. 3 A , N). Interaction studies 
with puri! ed recombinant MRN, MR, and NBS1 were compli-
cated by the fact that these proteins exhibited a signi! cant un-
speci! c binding activity toward the glutathione – Sepharose beads 
used in this analysis ( Fig. 3 B , beads alone). Nevertheless, we 
consistently observed a signi! cant enrichment of puri! ed MRN 
and partially puri! ed NBS1 when we used CK2-phosphorylated 
fragment M-3 in the pull-down assay ( Fig. 3, B and C ; bottom). 
Untreated M-3 or GST alone did not result in such enrichment. 
Similarly, neither phosphorylated nor unphosphorylated M-3 
was capable of ef! ciently binding to MRE11/RAD50 in the ab-
sence of NBS1 ( Fig. 3 C , top). In summary, these results indicate 
that the NBS1 subunit of the MRN complex directly associates 
probed with antibodies against RAD50, NBS1, and MRE11. (C) Mutation of a subset of the conserved SDT motifs abrogates NBS1 foci formation. (top) 
MDC1  – / –  MEFs were transiently transfected with various forms of HA-tagged full-length mouse MDC1, including wild-type (WT) and SDT-defi cient (3T > A: 
T362A, T387A, and T444A; 4T > A: T315A, T362A, T387A, and T444A; 5T > A: T300A, T315A, T362A, T387A, and T444A) variants. 48 h later, cells 
were irradiated, fi xed with methanol, and stained with antibodies against HA and mouse NBS1. (bottom) HA-positive cells were scored for NBS1 foci in 
wild-type and 5T > A-transfected populations (results were consistent in two independent datasets). (D) The SDT in MDC1 is phosphorylated in vivo. (top) A 
phosphospecifi c antibody raised against a doubly phosphorylated SDT peptide (pSDpT) was tested on CK2-phosphorylated GST-SDT. WT, mouse MDC1 
(amino acids 221 – 456); 6T > A, all six SDT motifs were mutated to SDA. (bottom) Immunoblot analysis of phosphorylated MDC1 isolated from HeLa nuclear 
extract by a H2AX phosphopeptide using the pSDpT phosphospecifi c antibody. (E) A synthetic biotinylated peptide comprised of the SDT sequence motif 
and phosphorylated on the Thr residue was either left untreated or was preincubated with  ! " PPase and CK2, respectively. (top) This leads to the three 
indicated products: unphosphorylated peptide, singly phosphorylated peptide (Thr), and doubly phosphorylated peptide (Ser and Thr). The peptides were 
then used to pull down proteins from HeLa nuclear extract. Proteins were detected as in B. Bar, 10  µ m. 
 
 Table I.  Tryptic MDC1 phosphopeptides 
 MDC1 tryptic peptide  CK2 phosphorylation site 
162-LLLAEDpSEEEVDFLSER-179 pS168
186-TTSSSVIVPESDEEGHSPVLGGLGPPFAFNLN(pSDpT)DVEEGQQPATEEASSAAR-238 +2PO 4 
247-QSEAEVVTEIQLEKDQPLVK-266 NA
292-SQPPGEDpSDpTDVDDDSRPPGRPAEVHLERAQPFGFIDpSDpTDAEEERIPATPVVIPMK-348 pS299, pT301, pS329, pT331
361-PGAPGLAHLQESQAGpSDpTDVEEGKAPQAVPLEKSQASMVINpSDpTDDEEEVSAALTLAHLK-420 pS376, pT378, pS402, pT404
445-SQTTTERDpSDpTDVEEEELPVENR-467 pS453, pT455
NA, not applicable.
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 Figure 5.  CK2 is essential for the interaction between MDC1 and NBS1 and for the accumulation of NBS1 at sites of DSBs in vivo.  (A) Down-regulation of 
CK2 ! and CK2 ! " by siRNA triggers a prolonged DDR. 72 h after transfection with siRNA duplexes, cells were irradiated and harvested at the indicated 
time points. Extracts were prepared and resolved by SDS-PAGE followed by immunoblotting. The blots were probed with the indicated antibodies. 
(B) Down-regulation of CK2 ! and CK2 ! " by siRNA abrogates NBS1 accumulation at sites of DSBs. 72 h after transfection with siRNA duplexes, cells were 
irradiated, fi xed with methanol, and stained with antibodies against  # -H2AX and NBS1. (C) Down-regulation of CK2 ! by siRNA disrupts the interaction 
between MDC1 and NBS1 in vivo. 72 h after transfection with siRNA duplexes, cells were lysed, and immunoprecipitation was performed using the 
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combinant CK2, and radioactive phosphate incorporation was 
measured by autoradiography ( Fig. 4 A ). This analysis revealed 
that all of the SDT motifs and other putative CK2 target sites 
were ef! ciently phosphorylated in vitro . 
 To test whether the highly conserved SDT repeats were 
necessary for the interaction with the MRN complex, we changed 
the conserved Thr residues to Ala within several SDT motifs 
and phosphorylated the isolated GST fusion proteins by CK2 in 
vitro. Signi! cantly, GST pull-down analysis with the mutant 
fragments revealed that only the phosphorylated wild type was 
capable of pulling down signi! cant quantities of the MRN com-
plex from HeLa nuclear extract, whereas alteration of the three 
C-terminal SDT motifs ( Fig. 4 A,  4 – 6) already reduced the inter-
action to almost background level ( Fig. 4 B ). 
 To test whether the SDT repeats of MDC1 mediate NBS1 
accumulation at sites of DSBs in vivo, we introduced the same 
SDT mutations as before ( Fig. 4 B ) in the tagged full-length mouse 
MDC1 cDNA followed by transient transfection of MDC1  – / –  MEFs 
with those mutants and assessment of MDC1 and NBS1 foci 
formation by indirect immuno" uorescence. Surprisingly, alter ation 
of the last three C-terminal SDT motifs ( Fig. 4 A , 4 – 6) did not 
trigger any signi! cant reduction in NBS1 foci formation ( Fig. 4 C , 
3T > A) even though the corresponding GST fusion protein only 
weakly interacted with the MRN complex in vitro ( Fig. 4 B , 
3T > A). However, mutation of four SDT motifs ( Fig. 4 A, 3 – 6) led 
to a detectable reduction in NBS1 accumulation even though small 
NBS1 foci were still detectable in a subset of the transfected cells 
( Fig. 4 C, 4T > A). Altering ! ve of the six SDT motifs ( Fig. 4 A, 
2 – 6) completely abrogated NBS1 foci formation in all MDC1-
positive cells ( Fig. 4 C,  5T > A). Signi! cantly, although the 5T > A 
mutant was unable to mediate NBS1 focal accumulation in re-
sponse to IR, it still localizes to foci itself, indicating that an intact 
SDT region is not required for MDC1 – ! -H2AX interaction. 
 Collectively, these results show that the SDT motifs are es-
sential for the interaction between MDC1 and the MRN com-
plex in vitro and for NBS1 accumulation at sites of DSBs in 
vivo, suggesting that the SDT motif may de! ne a novel phospho-
speci! c MRN-interacting element within MDC1. To test this di-
rectly, we ! rst sought to ascertain that the SDT motifs of MDC1 
are constitutively phosphorylated in vivo. To this end, we gener-
ated two phosphospeci! c antibodies against doubly phosphory-
lated SDT peptides (pSDpTs) derived from the human SDT 
repeat region (see Materials and methods for details). These 
antibodies were af! nity puri! ed and tested against the puri! ed 
CK2-phosphorylated GST-SDT fragment and its 6T > A mutated 
derivative. Although one of the two antibodies did not recognize 
the CK2-phosphorylated GST-SDT fragment (not depicted), the 
other antibody speci! cally recognized GST-SDT only when it 
was preincubated with CK2 and ATP ( Fig. 4 D , top). Signi! -
cantly, the 6T > A mutant was not recognized at all by this anti-
body, indicating that it is speci! c for doubly phosphorylated 
SDT repeats. We next used this antibody to detect MDC1 in extracts 
from undamaged and irradiated mammalian cells. Unfortunately, 
the pSDpT antibody unspeci! cally cross-reacted with many pro-
teins in whole cell and nuclear extracts, and, thus, we were un-
able to assess the MDC1 phosphorylation status in crude cell 
extracts ( Fig. 4 D , bottom; ! rst lane). However, MDC1 can be 
isolated along with the MRN complex from HeLa nuclear ex-
tract to near homogeneity by a phosphopeptide pull-down strat-
egy using a phosphopeptide derived from the H2AX C terminus 
(Fig. S2;  Stucki et al., 2005 ). When we probed the isolated 
MDC1 – MRN complex with the pSDpT antibody, we observed 
two bands at the position where MDC1 runs on SDS gels, indi-
cating that it is indeed phosphorylated on at least a subset of the 
SDT motifs in vivo ( Fig. 4 D , bottom; second lane). 
 To clarify whether the MRN complex interacts with a sin-
gle doubly phosphorylated SDT motif, we designed a biotinyl-
ated synthetic phosphopeptide comprising the sequence of one 
of the SDT motifs ( Fig. 4 A , 3), which was phosphorylated on 
the Thr residue. This peptide was either left untreated or was 
treated with  " phosphatase and CK2. Mass spectrometry and in 
vitro CK2 assays revealed that such treatment resulted in singly 
phosphorylated SDpT peptide, unphosphorylated SDT peptide, 
and doubly phosphorylated pSDpT peptide ( Fig. 4 E , top; and 
not depicted). Signi! cantly, only the doubly phosphorylated 
peptide, in which both Ser and Thr residues are being phosphor-
ylated, retrieved the MRN complex from HeLa nuclear extract 
( Fig. 4 E ). Collectively, these results suggest that doubly phos-
phorylated SDT motifs interact with MRN and determine MRN 
accumulation in vivo. 
 CK2 is essential for the interaction 
between MDC1 and NBS1 and for the 
accumulation of NBS1 at sites of DSBs 
in vivo 
 Because the SDT repeats are ef! ciently targeted by CK2 in vitro 
( Fig. 4 ), we next sought to investigate whether CK2 activity 
was required for NBS1 accumulation at sites of DSBs in vivo. 
Several commercial small-molecule CK2 inhibitors are available, 
and two of them were tested on human and mouse cells (TBB 
and DMAT). Surprisingly, neither of the two inhibitors triggered 
a detectable reduction in NBS1 foci formation in cultured hu-
man and mouse cells (unpublished data). Thus, we speculated 
that there may either exist additional acidophilic kinases that are 
capable of ef! ciently phosphorylating the SDT repeats in MDC1 
or that the inhibitors are not potent enough to completely elimi-
nate SDT phosphorylation in our experimental settings. 
 To test the latter possibility, we took an siRNA approach 
to down-regulate the two catalytic subunits of CK2 (CK2 # and 
CK2 # $ ) in U2OS cells. 72 h after siRNA transfection, CK2 # 
and CK2 # $ expression reached background levels ( Fig. 5 A ). 
At the same time, we observed massive cell death and severe 
mitotic defects, corroborating the essential role of CK2 in 
the cellular metabolism and life cycle. Interestingly, we also 
indicated antibodies. Proteins were separated by SDS-PAGE followed by immunoblotting. The blots were probed with antibodies against MDC1, NBS1, 
and CK2 # . Black lines indicate that intervening lanes have been spliced out. (D) MDC1 is associated with CK2 in vivo. HeLa cell extracts were used to 
immunoprecipitate proteins with the indicated antibodies. The immunocomplexes were separated by SDS-PAGE followed by immunoblotting. The blot was 
probed with antibodies against CK2 # and CK2 # $ . Bar, 10  µ m. 
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 Figure 6.  Disruption of the MDC1 – NBS1 interaction triggers a partial 
G2/M checkpoint defect.  (A) NBS-iLB1 fi broblasts and NBS-iLB1 fi broblasts 
stably transduced with wild-type NBS1 and R28A mutant NBS1 were ir-
radiated, fi xed with methanol, and stained with antibodies against MDC1 
and NBS1. (B) Whole cell extracts of NBS-iLB1 fi broblasts and NBS-iLB1 
fi broblasts stably transduced with wild-type (WT) NBS1 and R28A mutant 
NBS1 were resolved by SDS-PAGE followed by immunoblotting. The blot 
was probed with antibodies against NBS1 and tubulin. (C) NBS-iLB1 fi -
broblasts and NBS-iLB1 fi broblasts stably transduced with wild-type NBS1 
and R28A mutant NBS1 were left untreated or irradiated with 1 Gy and 
3 Gy, respectively. Cells were harvested 1 h after irradiation, fi xed with 
methanol, and stained with an antibody against phosphorylated H3 
(P-H3) and propidium iodine. The percentage of phosphorylated H3 –
 positive cells was determined by FACS analysis. Error bars represent SD. 
Bar, 10  µ m. 
 observed a prolonged phosphorylation of ATM substrates in re-
sponse to IR ( Fig. 5 A ), suggesting that down-regulation of CK2 
by siRNA may cause a repair defect. 
 Signi! cantly, down-regulation of either CK2 ! or CK2 ! " 
led to a marked defect in NBS1 foci formation in response to 
IR ( Fig. 5 B , left). At the same time, MDC1 accumulation at 
sites of DSBs was not signi! cantly reduced ( Fig. 5 B , right) even 
though the foci appeared smaller as compared with the foci in 
control siRNA-treated cells. This indicates that CK2 is essential 
for the accumulation of NBS1 at sites of DSBs, whereas it is 
dispensable for the interaction between MDC1 and  # -H2AX. 
 Next, we tested whether CK2 was required for the consti-
tutive interaction between MDC1 and NBS1. To this end, MDC1 
antibodies were used to coimmunoprecipitate NBS1 from ex-
tracts derived from siRNA-treated human cells. No NBS1 co-
immunoprecipitated with MDC1 from cells that were transfected 
with CK2 ! siRNA, whereas a small but signi! cant amount of 
NBS1 coimmunoprecipitated with MDC1 from cell extracts that 
were prepared from control siRNA-transfected cells ( Fig. 5 C ). 
The membrane was also probed with an antibody against CK2 ! 
to monitor the ef! ciency of CK2 ! depletion ( Fig. 5 C , bottom; 
note that CK2 ! corresponds to the faster migrating band). Inter-
estingly, we noticed that CK2 ! also coimmunoprecipitated with 
MDC1 ( Fig. 5 C , bottom; third and ! fth lanes), indicating that 
CK2 may exist in a complex with MDC1 in vivo. Indeed, anti-
bodies raised against MDC1 ef! ciently coimmunoprecipitated 
both CK2 ! and CK2 ! " from HeLa cell extracts ( Fig. 5 D ). 
Notably, the interaction does not change upon the introduction of 
DNA damage by IR ( Fig. 5 D , compare the last two lanes), indi-
cating that it is constitutive and not induced by DNA damage. 
 Collectively, these data reveal that CK2 is essential for NBS1 
foci formation and for the interaction between MDC1 and NBS1. 
In addition, CK2 exists in a complex with MDC1 and, thus, may 
be the primary kinase to target the SDT repeats in vivo. 
 Disruption of the MDC1 – NBS1 interaction 
triggers a partial G2/M checkpoint defect 
 As shown in Fig. 3 D, the R28A mutation in the NBS1 FHA do-
main triggers a severe defect in the association of NBS1 with 
the CK2-phosphorylated MDC1 SDT region in vitro ( Fig. 3 D ). 
Consistent with previous studies ( Cerosaletti and Concannon, 
2003 ;  Lee et al., 2003 ;  Horejsi et al., 2004 ), we also observed 
that this mutant is unable to accumulate in foci in stably trans-
duced NBS ! broblasts, whereas MDC1 accumulation is not af-
fected ( Fig. 6 A ). It was previously shown that the R28A mutant 
was not capable of rescuing the radiation sensitivity phenotype 
of NBS cells, whereas it did fully rescue the intra – S-phase 
checkpoint defect, at least at higher doses of irradiation ( Lee 
et al., 2003 ). In contrast, primary B cells derived from a human-
ized mouse model in which another key amino acid at the phos-
phopeptide recognition interface of the NBS1 FHA domain had 
been mutated to Ala (H45A) showed partial G2/M and intra – S-
phase checkpoint defects speci! cally at lower doses of irradiation 
( Di! lippantonio et al., 2007 ). To test whether the R28A muta-
tion causes a similar checkpoint defect, we measured alterations 
in the mitotic index in response to low (sublethal) doses of ir-
radiation (1 – 3 Gy) in NBS ! broblasts stably transduced with 
full-length wild-type and R28A NBS1. Consistent with previous 
! ndings ( Falck et al., 2005 ), NBS-iLB1 ! broblasts displayed 
a clear G2/M checkpoint defect in this dose range ( Fig. 6 C ). 
Stable transduction with wild-type NBS1 fully rescued the G2/M 
checkpoint arrest in response to 1 – 3 Gy of IR. However, stable 
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 Figure 7.  Model of the mechanism of the MDC1 – MRN interaction before 
and after DNA damage. See Discussion for details. 
transduction with R28A mutant NBS1 only partially restored the 
G2/M checkpoint, which is similar to the situation in the mouse 
B cells expressing the H45A mutant ( Fig. 6 C ;  Di! lippantonio 
et al., 2007 ). Notably, this checkpoint defect was not caused by 
lower expression levels of the mutant transgene as compared 
with the wild type ( Fig. 6 B ). Collectively, these results suggest 
that the constitutive CK2-dependent association of the MRN 
complex with MDC1 plays an important role in eliciting a full 
cell cycle checkpoint arrest. 
 Discussion 
 Previously, we and others have shown that MDC1 mediates accu-
mulation of the MRN complex at sites of DSBs ( Goldberg et al., 
2003 ;  Stewart et al., 2003 ;  Lukas et al., 2004 ;  Stucki et al., 2005 ). 
We also presented evidence that MDC1 exists in a complex with 
MRN in extracts from undamaged cells and that an intact NBS1 
FHA domain is essential for the stability of this interaction and 
for ef! cient retention of the MRN complex in  ! -H2AX – containing 
damaged chromatin regions ( Goldberg et al., 2003 ;  Lukas et al., 
2004 ;  Stucki et al., 2005 ). However, the precise mechanism by 
which MDC1 regulates the MRN complex remained unknown. 
 In this study, we identify a region in MDC1 that is essential 
for ef! cient accumulation of the MRN complex at sites of DSBs. 
This region of MDC1 features a repeated acidic sequence motif 
(the SDT motif), and our data, in combination with the accom-
panying study by Melander et al. (see p.  213 of this issue) and 
several recently published large-scale phosphorylation site screens 
of the human and mouse proteome ( Beausoleil et al., 2004 ; 
 Olsen et al., 2006 ;  Villen et al., 2007 ), suggest that at least a sub-
set of the SDT motifs in MDC1 are constitutively phosphory-
lated by the acidophilic kinase CK2 on highly conserved Ser and 
Thr residues. Furthermore, we present unexpected evidence that 
the doubly phosphorylated SDT motifs regulate accumulation 
and retention of the MRN complex in the DSB-" anking chroma-
tin compartment via a mechanism that involves direct interaction 
with the NBS1 N-terminal FHA domain. Finally, we show that 
CK2 is essential for NBS1 accumulation in damaged chromatin 
and that depletion of CK2 disrupts the MDC1 – MRN complex in 
vivo. Thus, our data successfully integrate and explain two 
observations whose interrelation has previously not been appre-
ciated: ! rst, we provide a mechanistic explanation as to why 
MDC1 and the MRN complex exist in a complex even before 
DNA damage; and second, our ! ndings also put into perspective 
the previous observation that an intact FHA domain of NBS1 is 
critical for ef! cient accumulation of the MRN complex at sites 
of DSBs ( Kobayashi et al., 2002 ;  Zhao et al., 2002 ;  Cerosaletti 
and Concannon, 2003 ;  Lee et al., 2003 ;  Horejsi et al., 2004 ; 
 Lukas et al., 2004 ) and for an intact DDR in living organisms 
( Di! lippantonio et al., 2005, 2007 ). 
 However, it is essential to appreciate that not all MRN 
functions seem to require MDC1. For instance, DNA end pro-
cessing activities of MRN do not appear to be dependent on 
MDC1 ( Jazayeri et al., 2006 ). Furthermore, there are no indica-
tions that MRN ’ s role in mediating ATM activation would re-
quire MDC1 ( Lee and Paull, 2005 ). Finally, MRN seems to 
occupy two distinct compartments at sites of DSBs: it accumu-
lates on single-stranded DNA regions generated by enzymatic 
resection of DSBs ( Jazayeri et al., 2006 ) as well as in large chro-
matin domains " anking DSBs that often span several thousand 
base pairs ( Bekker-Jensen et al., 2006 ). Although the accumula-
tion of MRN on single-stranded DNA does not require MDC1 
( Bekker-Jensen et al., 2006 ), accumulation and retention of MRN 
in  ! -H2AX – containing chromatin are critically dependent on 
MDC1 ( Goldberg et al., 2003 ;  Stewart et al., 2003 ;  Lukas et al., 
2004 ;  Stucki et al., 2005 ) and on CK2-dependent phosphorylation 
of its SDT repeats ( Melander et al., 2008 ; this study). 
 Based on these novel ! ndings and on previously published 
observations, we propose the following model of the events that 
occur before and after a cell has suffered genotoxic stress that 
generates DSBs ( Fig. 7 ): in the absence of DNA damage, MDC1 
is phosphorylated on multiple sites by CK2 and perhaps other 
constitutively active kinases. The MRN complex associates with 
MDC1 through direct interaction between the N-terminal FHA 
domain of the NBS1 subunit and the CK2-phosphorylated SDT 
repeat region of MDC1. Upon induction of DSBs in the genome, 
a fraction of MRN (that is probably not associated with MDC1) 
is rapidly deployed to the free DNA ends. Once bound to the 
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 ! -H2AX – containing damaged chromatin regions, an important 
step in the hierarchy of events that lead to the formation of nu-
clear foci at sites of DSBs has been resolved. Although we do 
not yet understand the function of MRN in the DSB-! anking 
chromatin compartment, one intriguing possibility is that MDC1-
bound MRN may act as a mediator of downstream phosphory-
lation events of the DDR. In this case, the MDC1 – MRN complex 
may enhance the DSB-induced signal by means of a positive 
feedback loop: MDC1 – MRN accumulates as the  ! -H2AX mark 
spreads into more distal chromatin regions, thus helping to trig-
ger a global DDR even in the presence of very low numbers of 
DSBs. Consistent with such a scenario is the observation that 
cells expressing NBS1 with a mutated FHA domain display 
a partial G2/M checkpoint defect at low doses of irradiation 
( Di" lippantonio et al., 2007; this study), whereas the check-
point seems to be normal at higher doses ( Di" lippantonio et al., 
2007 ). This suggests that the prevalent role of the MDC1 – MRN 
complex in checkpoint activation may not constitute the initia-
tion of the signal but rather its ampli" cation. The discovery of 
the SDT region of MDC1 and its speci" c role in MRN localiza-
tion in response to DNA damage will greatly facilitate the in-
vestigation of functional aspects of MRN in the DSB-! anking 
chromatin compartment. 
 Materials and methods 
 Cell culture and gene transfer 
 MDC1  – / –  and MDC1 +/+ MEFs were gifts from J. Chen (Yale University, 
New Haven, CT). NBS-iLB1 cells stably transduced with wild-type NBS1 
and R28A mutant NBS1 were gifts from S. Jackson (University of Cam-
bridge, Cambridge, UK) and K. Cerosaletti (University of Washington, Se-
attle, WA), respectively. MEFs, HeLa, U2OS, and NBS-iLB1 cells were 
cultured in DME (Invitrogen) supplemented with 10% FCS. Transfection of 
plasmids was performed using either Lipofectamine 2000 (Invitrogen) or 
calcium phosphate. Sf9 cells were cultured in Grace ’ s insect medium (Invit-
rogen) supplemented with 10% FCS. Recombinant MRE11, RAD50, and 
NBS1 baculoviruses were gifts from V. Bohr (National Institute on Aging, 
Baltimore, MD). The Bac-To-Bac Baculovirus Expression System (Invitrogen) 
was used to generate and amplify recombinant baculoviruses. All steps 
were performed according to the manufacturer ’ s protocols. CK2 inhibitors 
TBB and DMAT were purchased from EMD. Irradiation of MEFs was per-
formed in an x-ray cabinet (Faxitron) at 5 – 10 Gy/min. 
 Plasmids 
 The full-length mouse MDC1 cDNA was a gift from A. Nussenzweig 
(National Institutes of Health, Bethesda, MD) and was HA tagged at the 
C terminus by PCR and cloned into pcDNA3.1(+) mammalian expression 
vector (Invitrogen). Human MDC1-GST constructs were generated by PCR 
amplifi cation of the human MDC1 cDNA followed by cloning into pGEX4T3 
bacterial expression vector (GE Healthcare). Myc-NBS1 ( Falck et al., 2005 ) 
was subcloned into pFastBac transfer vector (Invitrogen) to generate recom-
binant NBS1 baculoviruses. Deletion mutants were generated by a stan-
dard PCR-based method, and point mutations were introduced using the 
QuikChange Site-Directed Mutagenesis kit (Stratagene). 
 siRNA and transfections 
 The siRNA duplexes were 21 bp with a two-base deoxynucleotide over-
hang (Dharmacon Research). The sequences of the CK2 " and CK2 " # 
siRNA oligonucleotides used were GAUGACUACCAGCUGGUUCdTdT 
and CAGUCUGAGGAGCCGCGAGdTdT, respectively. The control siRNA 
used was CGUACGCGGAAUACUUCGAdTdT. Cells were transfected 
with siRNA duplexes by using Oligofectamine (Invitrogen) according to 
the manufacturer ’ s instructions. Cells were routinely harvested 72 h after 
siRNA transfection. 
 Cell extraction and protein purifi cation 
 HeLa nuclear extract was purchased from Cilbiotech. Cell extraction for 
immunoblot analysis was described previously ( Stewart et al., 2003 ). 
DNA, MRN participates in a multitude of events that include 
DNA end processing and tethering of DNA molecules that may 
facilitate accurate repair as well as activation of the ATM signal-
ing cascade (for review see  Williams et al., 2007 ). Although the 
precise mechanisms of these processes are still not understood 
in detail, there is no experimental indication that the MRN com-
plex would require MDC1 for these functions. However, in a 
second step, after the ATM signaling cascade has been initiated, 
the MDC1-bound fraction of MRN enters the stage; once acti-
vated, ATM phosphorylates a vast variety of targets. Among 
these targets are H2AX molecules in nucleosomes that are lo-
cated close to the break site. Phosphorylated H2AX is recog-
nized by MDC1 through its C-terminal BRCT domains ( Stucki 
et al., 2005 ). MDC1, along with the MDC1-bound fraction of 
MRN, forms a tight complex with phosphorylated H2AX, thus 
recruiting more MRN to the chromatin compartments ! anking 
DSBs ( Stucki et al., 2005; Lou et al., 2006 ). This process is 
manifested by the formation of microscopically discernible nu-
clear foci containing both MDC1 and the MRN complex. 
 Although such a model of MDC1 – MRN interplay is in-
triguing, there are several outstanding issues that need to be dis-
cussed. It is clear that the interaction between MDC1 and the 
MRN complex is constitutive, but it is still dependent on the 
phosphorylation of MDC1 by CK2. A very similar mechanism 
has recently been described in two different aspects of the mam-
malian DDR, namely single-strand DNA break repair and DSB 
repair by nonhomologous end joining ( Koch et al., 2004 ;  Loizou 
et al., 2004 ). CK2 phosphorylates XRCC1, an adaptor protein 
that recruits several repair factors to single-stranded break sites 
( Loizou et al., 2004 ). In this case, the CK2 phosphorylation 
mark creates a binding site for the FHA domain – containing 
proteins polynucleotide kinase (PNK), aparataxin, and Xip1 
( Loizou et al., 2004 ;  Luo et al., 2004 ;  Bekker-Jensen et al., 
2007 ). In addition, PNK recruitment to sites of DSBs by XRCC4 
is also mediated by the CK2-dependent phosphorylation of 
XRCC4 ( Koch et al., 2004 ). Thus, the mechanisms of PNK, 
aparataxin, and Xip1 recruitment by XRCC1 and PNK recruit-
ment by XRCC4 closely resemble MRN chromatin retention by 
MDC1. However, although the recruitment of PNK by XRCC1 
was abolished by the CK2 inhibitor TBB ( Loizou et al., 2004 ), 
we were unable to abolish NBS1 recruitment to damaged chro-
matin by using the same inhibitor and other (even more potent) 
small-molecule CK2 inhibitors. One possible explanation for 
this discrepancy may lie in the existence of one or more CK2-
related acidophilic kinases that are capable of targeting the MDC1 
SDT repeats. However, the fact that down-regulation of CK2 
by siRNA completely abolishes NBS1 recruitment to damaged 
chromatin argues against this possibility but rather suggests 
that the CK2 inhibitors were not potent enough to reduce CK2 
activity suf" ciently to produce an effectual reduction in MDC1 
phosphorylation. Indeed, in vivo phosphorylation analysis of 
MDC1 by  Melander et al. (2008) reveals that treatment of cells 
with CK2 inhibitors maximally reduced SDT phosphorylation 
levels to 50%. This may not be enough for a visually discernible 
defect in NBS1 foci formation. 
 With the discovery of the mechanism by which MDC1 
mediates accumulation and retention of the MRN complex in 
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mass spectrometric phospho – amino acid analysis ( Jowsey et al., 2007 ). 
Mutation of putative CK2 phosphorylation sites in the GST-MDC1 fragment 
was performed using site-directed mutagenesis (Stratagene). 
 Checkpoint analysis 
 G2/M checkpoint analysis was performed as described previously ( Falck 
et al., 2005 ). In brief, cells were irradiated with the indicated doses during 
the exponential growth phase. 1 h later, cells were harvested, fi xed with 
70% ethanol/PBS, and incubated overnight at  ! 20 ° C. Fixed cells were 
washed with PBS and permeabilized with 0.25% Triton X-100/PBS on ice 
for 10 min. Cells were stained with an antiphosphohistone H3 antibody 
(Millipore) and propidium iodide. Data were acquired with a fl ow cytome-
ter (FC500; Becton Dickinson). 
 Phosphorylation site analysis by mass spectrometry 
 MDC1 samples that had been incubated with CK2 with or without ATP 
were subjected to electrophoresis on a 4 – 12% polyacrylamide gel that 
was stained with colloidal Coomassie blue. MDC1 bands were excised 
from the gel, washed with 0.1% NH 4 HCO 3 and 50% acetonitrile/50 mM 
NH 4 HCO 3 , reduced with 10 mM DTT in 0.1 M NH 4 HCO 3 for 45 min at 
65 ° C, and alkylated by the addition of 50 mM iodoacetamide for 30 min 
at room temperature. Gel pieces were then washed in 0.1% NH 4 HCO 3 
and 50% acetonitrile/50 mM NH 4 HCO 3 , dried, and incubated with 25 mM 
triethylammonium bicarbonate with 5  µ g/ml trypsin for 16 h at 30 ° C. 
For identifi cation of phosphorylation sites, the extracted tryptic peptides 
were analyzed by liquid chromatography mass spectrometry on a spec-
trometer (4000 Q-TRAP; Applied Biosystems) with precursor ion scanning 
as described previously ( Williamson et al., 2006 ). The tandem mass spec-
trometry spectra were searched against a local database containing the 
GST-MDC1 sequence using the Mascot search algorithm (www.matrix-
science.com) run on a local server. Sites of phosphorylation were validated 
by manual inspection of the mass spectrometry spectra using Analyst 1.4.1 
software (MDS Sciex). 
 Online supplemental material 
 Fig. S1 shows a sequence alignement of the SDT repeats in human, mouse, 
zebrafi sh, and honey bee MDC1. Fig. S2 shows the purifi ed MDC1 – MRN 
complex isolated from HeLa nuclear extract. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200709008/DC1. 
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Spycher et al. Figure S1
Figure S1. Sequence alignment of the SDT motifs in human, mouse, zebrafish, and bee 
MDC1. Alignment was performed with ClustalX for Mac OS X (Thompson, J.D., T.J. Gibson, F. 
Plewniak, F. Jeanmougin, and D.G. Higgins. 1997. Nucleic Acids Res. 25:4876–4882), and the 
shading was generated by using Boxshade 3.21 (www.ch.embnet.org). Bee MDC1 was 
identified based on structural alignment of the C-terminal  BRCT domains (Stucki, M., J.A. 
Clapperton, D. Mohammad, M.B. Yaffe, S.J. Smerdon, and S.P. Jackson. 2005. Cell. 123:1213–
1226). The consensus of all  analyzed species is d-S-d-T-D/E-x-E, which conforms to consensus 
CK2 phosphorylation sites (S/T-X-X-D/E) for both Ser and Thr residues. The highlighted 
sequences are the conserved amino acids within the SDT motifs.
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Figure S2. Purification of the MDC1–MRN complex from HeLa nuclear extract. H2AX 
phosphopeptide pull down was performed as described previously (Stucki, M., J.A. Clapperton, 
D. Mohammad, M.B. Yaffe, S.J. Smerdon, and S.P. Jackson. 2005. Cell. 123:1213–1226), but 
the beads were extensively washed with a high-stringency buffer (50 mM Tris-HCl, pH 8.0, 200 
mM NaCl, and 0.5% NP-40). The bound proteins were eluted with SDS loading buffer and 
separated on an SDS-polyacrylamide gel  followed by silver staining. The protein bands were 
identified by parallel immunoblot analysis using antibodies against human MDC1, RAD50, 
NBS1, and MRE11 (not depicted).

5.2 MDC1-dependent retention of the MRE11-RAD50-NBS1 complex in 
damaged chromatin is not required for activation of the G2/M DNA 
damage checkpoint
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• Gathering the data for Fig. 1B, 2B, and 3
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Abstract 
The MRE11/RAD50/NBS1 (MRN) complex accumulates at sites of DNA 
double-strand breaks in large chromatin domains flanking the lesion site. The 
mechanism of MRN accumulation involves direct binding of the NBS1 subunit to 
phosphorylated MDC1, a large nuclear adaptor protein that directly interacts 
with phosphorylated H2AX (!H2AX). NBS1 contains an FHA domain and two 
BRCT domains at its N-terminus. Here we present evidence that both of these 
domains participate in the interaction between MDC1 and NBS1. Point 
mutations in key amino acid residues of either the FHA or the BRCT domains 
compromise the interaction with MDC1 and lead to defects in MRN 
accumulation at sites of DNA damage. Surprisingly though, only mutations in 
the FHA domain, but not mutations in the BRCT domains, yield a G2/M 
checkpoint defect. This indicates that MDC1-dependent chromatin accumulation 
of the MRN complex at site of DNA breaks is not required for G2/M checkpoint 
activation. 
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Introduction 
 
Nijmegen breakage syndrome (NBS) is a rare autosomal genetic disorder. 
NBS patients suffer from growth retardation, microcephaly, dismorphal features, 
immunodeficiency and predisposition to cancer, mainly lymphomas. Cells derived 
from NBS patients are radio-sensitive, show chromosomal instability and cell cycle 
checkpoint as well as apoptotic defects (1)}(2). 
The NBS gene codes for a 754 amino acid protein named NBS1 (p95; nibrin). 
It exclusively exists in a complex with two enzymes: MRE11, a structure-specific 
nuclease and RAD50, an ATPase/adenylate kinase. Together, these three proteins 
form the MRE11/RAD50/NBS1 (MRN) complex, a conserved and essential DDR 
factor that functions in a multitude of cellular processes involving DNA double-strand 
breaks (DSBs), including DSB repair, checkpoint signaling, DNA replication, meiotic 
recombination and induction of apoptosis (2,3). 
The MRN complex accumulates at sites of DSBs in large microscopically 
discernible subnuclear structures, usually referred to as DNA damage foci. The 
functional implication of this massive accumulation at sites of DSBs is not yet fully 
understood. We and others recently showed that focus formation by the MRN 
complex is mediated by a direct interaction between NBS1 and phosphorylated 
MDC1, a large nuclear adaptor protein that specifically recognizes phosphorylated 
H2AX (4-7). The interaction between NBS1 and MDC1 is dependent upon the N-
terminal FHA domain of NBS1 that directly interacts with a constitutively 
phosphorylated acidic repeat region in MDC1 (the SDT repeat; (4-6)).  
No structural information of full-length NSB1 is yet available, but recent 
NMR structural data suggested that besides the FHA domain, NBS1 may also feature 
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a tandem BRCT domain at its N-terminus (8). Like FHA domains, tandem BRCT 
domains have been shown to act as phospho-specific protein-protein interaction 
modules (9). Interestingly, point mutations altering key residues in the tandem BRCT 
domain of NBS1 seem to disrupt foci formation by the MRN complex, similar to 
point mutations altering key residues in the FHA domain, thus indicating that besides 
the FHA domain, the BRCT domains of NBS1 may also participate in MDC1 binding 
(8,10).  
Here we present evidence that like the FHA domain, the tandem BRCT 
domain of NBS1 specifically interacts with phosphorylated MDC1. We show that a 
single point mutation in a key residue within the tandem BRCT domain of NBS1 
abrogates accumulation of the MRN complex at sites of DSBs. Surprisingly though, 
this mutation does not trigger a G2/M checkpoint defect, indicating that MDC1-
mediated accumulation of the MRN complex at sites of DSBs is not required for 
G2/M checkpoint activation. 
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Results and discussion 
 
The NBS1 tandem BRCT domain is not required for SDT 
phosphopeptide binding. 
Until recently, sequence comparison and structure predication algorithms 
indicated that the N-terminal region of NBS1 contained an FHA domain and one 
single BRCT domain (reviewed in (11)). Three years ago, a second putative BRCT 
domain at the N-terminus of NBS was discovered by means of a refined bioinformatic 
analysis (12). The existence of two BRCT domains downstream of the FHA domain 
at the NBS1 N-terminus was partially confirmed by a recently published NMR 
structure of the second (more C-terminal) BRCT domain (8). Interestingly, there is no 
spacer between the FHA domain and the putative tandem BRCT domain, indicating 
that these domains may form one single compact globular structure (see Figure 1A). 
Moreover, the conservation of key phospho-binding amino acid residues in the BRCT 
tandem domain suggests that like the FHA domain, it may act as a phospho-specific 
protein-protein interaction module.  
We and others recently showed that the FHA domain of NBS1 directly 
associates with a constitutively phosphorylated region in MDC1, the SDT repeat 
region (also termed SDTD repeat region; (4-6)). The SDT repeat region consists of 
several conserved patches of eight to ten amino acids, interspersed with less 
conserved regions of variable length. The conserved patches feature a repeated 
sequence motif: Ser and Thr residues are embedded in an acidic sequence 
environment. A single amino acid (typically Asp) sits in between the highly 
conserved Ser and Thr residues. Both Ser and Thr residues are constituively 
phosphorylated by Caseine kinase 2. Mammalian MDC1 contains a total of six SDT 
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motifs, and at least five of these are required for efficient MRN accumulation at sites 
of DSBs (4). 
It was recently suggested that the tandem BRCT domain of NBS1 may 
contribute to the stable association of NBS1 with the phosphorylated SDT region of 
MDC1 (8). This hypothesis was based on the observation that mutations in conserved 
amino acids in the second (C-terminal) BRCT domain led to defective NBS1 
accumulation at sites of DSB (8). However, this analysis was carried out with over 
expressed proteins in Hela cells that express normal levels of endogenous NBS1.  
In order to test if the BRCT tandem domain of NBS1 would contribute to the 
interaction with the phosphorylated MDC1 SDT region, we first designed a 
biotinylated synthetic phosphopeptide comprising the sequence of one of the SDT 
motifs and being phosphorylated on both the Ser and Thr residues (Figure 1B; top). 
To confirm that this peptide was capable to efficiently interact with NBS1, it was 
either left untreated or it was treated with Lambda phosphatase (!-PPase) and was 
then used in a peptide pull down experiment with Hela nuclear extracts. Similar to 
previously published data, the phosphorylated peptide pulled down significant 
amounts of three proteins that were identified as RAD50, NBS1 and MRE11 (Figure 
1B; (6)). Next, to test if efficient association of full-length NBS1 with this 
phosphopeptide required the intact BRCT tandem domain, we generated a number of 
point mutations in the full length NBS1 cDNA, targeting conserved amino acids that 
mediate direct contact with phosphorylated peptides. We chose conservative 
mutations to preserve the structure of the tandem BRCT domain (see Figure 1A; 
highlighted amino acids). These mutants were expressed in rabbit reticulocyte lysates 
(despite many attempts, we were unable to express soluble recombinant NBS1 in 
other expression systems) and tested for phosphopeptide binding in a pull down assay. 
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Interestingly, we observed that only mutations in the FHA domain (R28A; H45A) 
abrogated the interaction with the pSDpT peptide, while mutations in the BRCT 
tandem domain (S118A, K160M, K233A) showed similar affinity to the 
phosphopeptide binding as the wild type NBS1 (Figure 1C). These findings suggest 
that stable binding of NBS1 to an immobilized SDT phosphopeptide does not require 
the tandem BRCT domain. 
 
The tandem BRCT domain of NBS1 contributes to the interaction with 
the full-length phosphorylated SDT region of MDC1. 
The MDC1 SDT region contains at least 5 phosphorylated SDT motifs that are 
essential for efficient NBS1 binding (4). This may indicate that more than one binding 
site with affinity to the phosphorylated SDT region may exist in NBS1. Thus, we 
decided to test whether the intact NBS1 BRCT tandem domain was required for the 
efficient association of NBS1 with the full-length phosphorylated SDT region. To this 
end, we phosphorylated (or mock treated) a GST-tagged SDT fragment and assessed 
its ability to interact with the in vitro-translated wild type NBS1 and its FHA and 
BRCT mutated derivative, respectively. Both an FHA domain mutant (R28A) and a 
BRCT tandem domain mutant (K160M) still interacted with the phosphorylated SDT 
region of MDC1 (Figure 2A). However, a double phosphopeptide-binding mutant 
where both FHA and tandem BRCT domain are targeted (R28A/K160M), showed no 
significant binding to the phosphorylated SDT region anymore. This indicates that 
both the FHA domain and the BRCT tandem domain are capable to interact with the 
phosphorylated full-length SDT region in vitro. 
NBS1 does not exist on its own in the nuclei of mammalian cells, as it is 
always associated with MRE11 and RAD50. Thus, our assay conditions with the in 
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vitro-translated NBS1 does not very well reflect the in vivo situation. Therefore, we 
co-expressed all three subunits of the MRN complex in insect cells and tested their 
binding affinity to the phosphorylated SDT region of MDC1. As shown before, also 
in the context of the entire MRN complex, wild type NBS1 efficiently bound to the 
phosphorylated SDT region (Figure 2B; (4)). Surprisingly though, neither the FHA 
mutant (R28A) nor the BRCT tandem domain mutant (K160M) was capable to 
associate with the phosphorylated SDT region (Figure 2B). This indicates that when 
NBS1 exists in a complex with MRE11 and RAD50, both the FHA domain and the 
BRCT tandem domain of NBS1 are required for stable association with MDC1. It is 
currently not clear why the in vitro-translated NBS1 single mutants still interacted 
with the phosphorylated SDT region while in the context of the full MRN complex, 
they did not. But it is possible that when NBS1 is an integral part of the MRN 
complex, its N-terminal phosphopeptide binding region may be sterically less flexible 
so that efficient association with the SDT region is only possible when both FHA 
domain and BRCT tandem domain are contributing to the interaction. 
 
The BRCT tandem domain of NBS1 is required for efficient accumulation 
of the MRN complex at sites of DSBs, but not for the induction of the G2/M DNA 
damage checkpoint. 
It has previously been shown that deletion of the first (N-terminal) BRCT 
domain leads to a defect in MRN accumulation at sites of DSBs (13,14). Moreover, 
point mutations in this domain that are thought to disrupt the structure also had a 
negative impact upon foci formation by the MRN complex (10). This may indicate 
that the BRCT tandem domain of NBS1 is also required for efficient MRN 
accumulation. However, since the FHA domain and the BRCT tandem domain may 
form one single globular domain at the NBS1 N-terminus (see above), it is also 
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possible that structure-disrupting mutations and/or deletion of an entire BRCT domain 
may also compromise the structure of the FHA domain. Thus, we saught to 
investigate whether a conservative K160M mutation in the BRCT domain that 
preserves the BRCT structure would also compromise the accumulation of the MRN 
complex at sites of DSBs. To this end, we took the well-established approach of UV-
laser microirradiation to induce DSBs in subnuclear volumes of NBS fibroblasts 
stably transduced with full-length wild type, R28A and K160M NBS1 (15). Under 
these conditions, wild type NBS1 accumulated throughout the microirradiated nuclear 
compartments (Figure 3A). However, mutation in either the FHA domain (R28A) or 
the BRCT tandem domain (K160M) prevented NBS1 binding to the !H2AX-coated 
areas except for a small fraction of the protein scattered along the irradiated path 
(Figure 3A; see enlarged areas). This indicates that phospho-specific binding of the 
BRCT tandem domain (presumably to the MDC1 SDT region) is essential for 
efficient accumulation of the protein in damaged nuclear areas.  
We previously proposed that MDC1-mediated accumulation of the MRN 
complex in chromatin regions flanking DSBs was required for the efficient activation 
of the G2/M DNA damage checkpoint. This was based on the observation that point 
mutations in the FHA domain that disrupt its phospho-specific binding, display partial 
G2/M checkpoint defects (4,16,17). So we reasoned that since mutations in the BRCT 
domains also lead to defective MDC1 binding and thus, to reduced chromatin 
accumulation at sites of DSBs, they should yield a similar G2/M checkpoint defect as 
FHA domain mutants. Surprisingly though, we found that NBS fibroblasts stably 
transduced with K160M NBS1 efficiently activated the G2/M checkpoint (Figure 3B). 
This indicates that MDC1-binding and MDC1-mediated accumulation of the MRN 
complex at sites of DSBs is not required for the activation of the G2/M checkpoint. 
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Moreover, our findings also suggest that the FHA domain of NBS1 may have 
additional binding partners besides MDC1, and that association of NBS1 with these 
binding partners may regulate G2/M checkpoint activation. 
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Material and Methods 
 
Cell culture and gene transfer 
NBS-iLB1 cells stably transduced with wild type NBS1 and R28A mutant 
NBS1 were kind gifts from Steve Jackson (University of Cambridge, UK) and Karen 
Cerosaletti (University of Washington, USA), respectively. NBS1-iLB1 stably 
expressing the K160M mutant NBS1 were generated by retroviral transduction of the 
NBS1 cDNA cloned into the pBABE puro retroviral vector. Sf9 cells were cultured in 
Grace's insect medium (Gibco) supplemented with 10% fetal calf serum. 
Recombinant MRE11, RAD50 and NBS1 baculoviruses were a kind gift from 
Vilhelm Bohr (NIA, Baltimore, USA). Bac-To-Bac Baculovirus Expression System 
(Gibco) was used to generate and amplify recombinant baculoviruses. All steps were 
carried out according to the manufacturer's protocols.  
Irradiation of NBS1-iLB1 cells was carried in a Faxitron X-ray cabinet at 5-10 
Gy/min. or by means of single-cell laser microirradiation (see below). 
 
Plasmids 
Human MDC1-GST constructs were described (4). Myc-NBS1 (18) was 
subcloned into pFastBac transfer vector (Gibco) to generate recombinant NBS1 
baculoviruses and into pBABE puro to generate retroviral particles, respectively. 
Point mutations were introduced using the QuickChange site-directed mutagenesis kit 
(Strategene). 
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Cell extraction and protein purification 
Hela nuclear extract was purchased from Cilbiotech (Mons, Belgium). MDC1-
GST-SDT fragment was affinity purified on Glutathione-Sepharose (GE Healthcare 
Biosciences). Recombinant MRN purification from Sf9 cells was described (4). For in 
vitro-translation of NBS1, the TNT system (Promega) was used. 
 
Microirradiation and single-cell analysis 
In order to generate DSBs in defined nuclear volumes laser microirradiation 
was performed with a MMI CELLCUT system containing a 355 nm UVA laser (55 
Hz, Molecular Machines & Industries, Switzerland) coupled to an Olympus IX71 
microscope station and focused through an LUCPLFLN 40X objective. The 
MMICELLTOOLS software with MMIUVCUT plug-in assisted the laser operation 
using an energy output of 55% (unless stated otherwise). Prior to laser irradiation, 
cells were grown on coverslips in cell culture dishes in the presence of 10 µM BrdU 
(Bromodeoxyuridine; Sigma) for 24 h. Coverslips were then transferred into LabTek 
chamber slides (Nunc) and mounted on the microscope stage for irradiation. After 
irradiation, cells were placed back in the incubator for 30-60 min before fixation.  
 
 
Antibodies and immunological techniques 
Antibodies against human NBS1 and !H2AX were obtained from Upstate 
Biotechnology.  
For immunofluorescence staining, cells were grown on glass coverslips, fixed 
in ice-cold methanol and stained with the indicated antibodies for 1h at room 
temperature. Secondary antibodies were from Jackson laboratories (FITC and 
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Rhodamine) and Invitrogen (Alexa-488 and Alexa-596). Images were captured at 
room temperature on a Leica SP2 confocal microscope (Leica Microsystems) with a 
40x (oil immersion, NA 1.25) objective. 
 
Biochemical analysis 
For peptide pull down analysis, the biotinylated synthetic peptide Btn-NH-
SGSFID[pS]D[pT]DAEEERI-COOH (Eurogentec) was used. Where indicated, 25 
nmol of the peptide were incubated with 100 U !!PPase (New England BioLabs) at 
30°C for 20 min. Peptide pull down analysis from Hela nuclear extract was done as 
described (19). Peptide pull down analysis with in vitro-translaged NBS1 was done by 
incubating 25 nmol of the peptide with 1/5 volume of a standard TNT reaction. 
For GST pull down assays, purified GST-fusion proteins (5 !g) were mixed 
with 1/5 volume of a standard TNT reaction and 5 !g of purified MRN, respectively. 
Where indicated, GST fusion proteins were pre-treated with 100 U of CK2 (New 
England BioLabs). The mixture was incubated for at 4°C for 30 min. to allow 
binding. Glutathione sepharose beads were then added and the suspension was 
incubated at 4°C for further 60 min. The beads were washed 3 times with wash buffer 
(50mM Tris pH 7.5, 120 mM NaCl, 1 mM DTT, 0.2% NP-40), resuspended in SDS 
loading buffer and analyzed by SDS polyacrylamide gel electrophoresis and 
immunoblotting. 
 
Checkpoint analysis 
G2/M checkpoint analysis was done as described (Falck et al., 2005). Briefly, 
cells were irradiated with the indicated doses during the exponential growth phase. 1h 
later, cells were harvested, fixed with 70% ethanol/PBS and incubated over night at -
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20°C. Fixed cells were washed with PBS and permeabilized with 0.25% Triton/PBS 
on ice for 10min. Cells were stained with an anti-phospho-histone H3 antibody 
(Upstate) and propidium iodide. Data were acquired with a Becton Dickinson flow 
cytometer. 
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Figure legends 
 
Figure 1: The NBS1 tandem BRCT domain is not required for SDT 
phosphopeptide binding. 
A Schematic representation of full-length human NBS1 and its domain composition. 
The enlarged area shows a sequence alignment of the FHA and BRCT domains of 
human, mouse and Xenopus NBS1. The putative secondary structure of the first (N-
terminal) BRCT domain is indicated by pale colors. The secondary structure of the 
second (C-terminal) BRCT domain (full colors) was derived from (8). Phospho-
interacting amino acids are highlighted in yellow and a putative +3 interacting Lys 
residue is highlighted in ocre. 
B A synthetic biotinylated peptide comprising the SDT sequence motif and being 
phosphorylated on the Ser and Thr residue was left untreated and pre-incubated 
!!PPase, respectively. The peptides were then used to pull down proteins from Hela 
nuclear extract. The sequence of the peptide is shown on top. 
C The synthetic biotinylated peptide shown in B was was left untreated and pre-
incubated !!PPase, respectively. The peptides were then incubated with in vitro-
translated 
35
S-labeled NBS1 wild type or mutants for 1 h, washed, and resolved by 
SDS-PAGE and autoradiography. 
 
Figure 2: The tandem BRCT domain of NBS1 contributes to the interaction with 
the full-length phosphorylated SDT region of MDC1. 
A Purified MDC1 GST-SDT fragment was pre-incubated with CK2 and ATP. The 
fragment was then incubated with in vitro-translated 
35
S-labeled NBS1 wild type or 
mutants for 1 h, washed and resolved by SDS-PAGE and autoradiography. 
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B Purified MDC1 GST-SDT fragment was pre-incubated with CK2 and ATP. The 
fragment was incubated with purified MRN complex where the NBS1 subunit was 
either wild type or contained a point mutation in the FHA domain (R28A) or in the 
BRCT tandem domain (K160M). Bound proteins were separated on SDS 
polyacrylamide gels followed by immunoblotting. The blots were probed with a 
polyclonal antibody against NBS1. 
 
Figure 3: The BRCT tandem domain of NBS1 is required for efficient 
accumulation of the MRN complex at sites of DSBs, but not for the induction of 
the G2/M DNA damage checkpoint. 
A NBS-iLB1 fibroblasts stably transduced with wild type NBS1 and R28A and 
K160M mutant NBS1, respectively, were micro-irradiated as described in Material 
and Methods. Irradiated cells were incubated for 1 h, fixed with methanol and probed 
with the indicated antibodies. Cells were then analyzed by confocal microscopy. 
B NBS-iLB1 fibroblasts and NBS-iLB1 fibroblasts stably transduced with wild type 
NBS1 and R28A and K160; mutant NBS1, respectively were left untreated or 
irradiated with 1 Gy and 10 Gy, respectively. Cells were harvested 1 hour after 
irradiation, fixed with methanol and stained with an antibody against phosphorylated 
H3 (P-H3) and propidium iodine. The percentage of P-H3 positive cells was 
determined by FACS analysis. 
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5.3 Molecular basis of ATM and FHA-dependent MDC1 dimerization in 
response to DNA damage
My contribution to this work was:
• Design and cloning of GST-MDC1 constructs (Figure 1A)
• Expression and purification of GST-MDC1 fragments (Figure 1A)
• In vitro ATM kinase assay with GST-MDC1 protein fragments (Figure 1A)
• Phospho-peptide pull down assay with pT4-peptide (Figure 2B)
• Phospho-peptide pull down with purified FHA and BRCT fragments (Figure 2C)
• Silver-stained SDS PAGE of phospho-peptide pull down (Figure S2)
• Proofreading of the manuscript
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Abstract 
 
Mediator of the DNA-damage Checkpoint-1 (Mdc1) is a large modular 
phosphoprotein that acts as a scaffold for assembly and maintenance of signaling and 
repair complexes at double-stranded DNA break sites. Mdc1 is anchored to damaged 
chromatin through interaction of its C-terminal BRCT-repeat domain with the 
phosphorylated tail of !H2AX following DNA damage, but the role of the N-terminal 
FHA domain remains largely obscure. Here, we show that the FHA domain binds both 
in vitro and in human cells to a novel DNA-damage and ATM-dependent 
phosphorylation site located at Thr-4 within the extreme Mdc1 N-terminus. We further 
show that while the isolated FHA domain forms phospho-independent dimers, self-
association is substantially stabilised by Thr-4 phosphorylation. The X-ray structure of 
free and phosphopeptide-bound dimeric Mdc1 FHA domain reveals that dimerisation 
occurs in a 'head-to-tail' manner reminiscent of the arrangement often proposed for 
ATM-phosphorylated Chk2 kinase. Together, our observations highlight a novel 
mechanism for DNA-damage-regulated mediator dimerisation and suggest a more 
general significance of FHA-FHA interactions in other cellular signaling contexts. 
 
Key words: DNA damage / ATM  / chromatin / FHA domain / dimerisation 
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Introduction 
 
Genomic integrity is constantly challenged by the effects of DNA-damaging agents. 
Double-stranded DNA breaks (DSBs) are considered to be the most genotoxic of the variety 
of different lesions that occur since incorrect repair can lead to chromosome breaks and other 
aberrations that are characteristic of and which may lead to cancer. The occurrence of DSBs 
initiates a program of cellular responses involving activation of cell-cycle checkpoints and 
deployment of the repair machinery. Central to DNA-damage response (DDR) regulation is a 
protein kinase cascade involving ataxia telangiectasia-mutated kinase (ATM) which acts as 
sensor of double-stranded breaks propogating damage signals through phosphorylation of 
checkpoint kinases and other diverse downstream targets. Many of these phosphorylation 
events are now known to sponsor protein-protein interactions mediated by 
phosphoserine/threonine-specific binding domains, most commonly forkhead-associated 
(FHA) and Brca1 C-terminal (BRCT) modules (Mohammad & Yaffe, 2009), providing for 
highly regulated, physical links between DDR components.  
Mdc1 is a large (2089 aa), modular protein originally identified as an essential factor 
for establishment of the S-phase checkpoint (Goldberg et al, 2003; Lou et al, 2003a; Stewart 
et al, 2003). It is now known to function as an assembly platform for the localization and 
maintenance of signaling and repair factors at and around DSB sites (van Attikum & Gasser, 
2009). As such, Mdc1 is the founding member of a class of large scaffolding/adaptor proteins 
known as 'mediators' that includes proteins such as human 53BP1 and yeast Rad9 and Crb2. 
While all of these molecules contain two or more copies of BRCT-repeat motifs, Mdc1 alone 
contains an additional FHA domain at its N-terminus.  
Functionally, the C-terminal BRCT-repeats tether Mdc1 to regions of DNA-damage 
by virtue of their specific binding to ATM-phosphorylated H2AX (known as !H2AX), a 
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variant histone H2A which acts as the primary marker of damaged chromatin in all eukaryotic 
cells (Stucki et al, 2005). In contrast, the function of the FHA domain is less clear but has 
been suggested to include interaction with ATM itself (Lou et al, 2006), Chk2 (Lou et al, 
2003a) and other repair proteins such as Rad51 (Zhang et al, 2005). In addition, although self-
association has been shown to be a functional feature of 53BP1 (Zgheib et al, 2008), Rad9 
(Soulier & Lowndes, 1999) and Crb2 (Kilkenny et al, 2008), the oligomeric status of Mdc1 in 
DNA-damaged cells has not, to our knowledge, been investigated. Using a combined 
biochemical, cell-biological and structural approach, we now show that the Mdc1 FHA 
domain mediates an inter-molecular interaction with a previously uncharacterized, ATM 
phosphorylation site located near the Mdc1 N-terminus, revealing a role for DNA-damage 
inducible Mdc1 dimerisation in the cellular response to double-stranded DNA breaks. 
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Results 
Threonine-4 is a novel site of ATM phosphorylation in vitro and in vivo.  
Mdc1 contains many potential PIKK target sites (S/TQ-motives) throughout its open 
reading frame and early studies have shown that upon genotoxic stress, Mdc1 is rapidly 
phosphorylated in a PIKK-dependent manner (Goldberg et al, 2003; Lou et al, 2003a; Stewart 
et al, 2003). However, only few of these potential PIKK target sites are conserved and the 
extent and physiological relevance of PIKK-dependent Mdc1 phosphorylation are largely 
unknown. In order to identify bona fide PIKK target sites in Mdc1, we generated eight 
overlapping fragments of the human Mdc1 cDNA and expressed them in E. coli as GST-
fusion proteins (Figure 1A; top and (Spycher et al, 2008)). Seven fragments were expressed 
well and were purified (Figure 1A, upper panel) whereas one fragment (M-6) comprising the 
Mdc1 PST repeat region was not expressed in bacteria. 
The purified GST fragments were subjected to an in vitro kinase assay with 
immunoprecipitated human ATM (Hickson et al, 2004). Surprisingly, purified ATM only 
phosphorylated fragment M-1 (amino acids 1-124) and fragment M-4 (amino acids 531-770), 
but none of the other five fragments (Figure 1A, lower panel). Fragment M-4 features a 
cluster of three conserved T-Q-X-F motifs that have recently been shown to form binding 
sites for the FHA domain of the ubiquitin ligase RNF8 following phosphorylation by ATM 
(Huen et al, 2007; Kolas et al, 2007; Mailand et al, 2007). Fragment M-1 contains two 
conserved TQ motifs: one at the very N-terminus of Mdc1 (T4/Q5) and one within the FHA 
domain (T98/Q99). Thr-4 appears to be the major site of ATM phosphorylation since a 
deletion mutant of M-1 lacking the first 18 amino acids was not phosphorylated by ATM in 
vitro (Figure S1) while a point mutation altering T4 to Ala (T4A) resulted in a protein that 
could no longer be phosphorylated by ATM in vitro (Figure 1B). 
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In order to investigate Thr-4 phosphorylation in vivo, we raised a phosphospecific 
antibody directed against a pT4 peptide derived from the Mdc1 N-terminus (T4p). This 
antibody recognized the in vitro phosphorylated M-1 fragment and cross-reacted only 
minimally with the unphosphorylated form of M-1 (Figure 1B, third panel). Moreover, the 
antibody did not recognize the T4A mutant M-1 fragment, even after ATM phosphorylation, 
indicating that this antibody is specific for the pT4 site. We then exposed U2OS cells to 
various doses of IR and analyzed total cell extracts by immunoblotting with the T4p antibody. 
The antibody cross-reacted with several proteins in total cell extracts, but one band (running 
at approximately 250 kDa) only emerged in extracts derived from cells that had been treated 
with IR. The intensity of this band increased with increasing dose of IR (Figure 1C; left 
panels). Stripping and re-probing the blot with an antibody against human Mdc1 revealed that 
the protein recognized by the T4p overlapped with at least one of the Mdc1 size variants. 
Time course analysis showed that 1 h post irradiation, phosphorylation levels were maximal 
and then slowly decreased. 21 hours post IR, the phosphorylation signal approached 
background levels (Figure 1C; right panels). 
To exclude the possibility that the T4p antibody cross-reacted with another protein 
phosphorylated in response to IR, we subjected Mdc1
–/–
 mouse embryonic fibroblasts and 
control (Mdc1
+/+
) cells to various doses of IR and analyzed total cell extracts by 
immunoblotting using the T4p antibody. In extracts prepared from irradiated Mdc1
+/+
 MEFs, 
a clear signal appeared on polyacrylamide gels at the position where mouse Mdc1 would be 
expected. No such signal was detected in extracts derived from irradiated Mdc1
–/–
 cells, 
indicating that the protein recognized by the T4p antibody indeed corresponds to Mdc1 
(Figure 1D). 
Mdc1 phosphorylation in response to IR is ATM-dependent (Goldberg et al, 2003; 
Lou et al, 2003b; Stewart et al, 2003). Consistent with this, no Mdc1 signal was detected by 
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the T4p antibody in extracts from irradiated cells that had been pre-treatment with a specific 
ATM inhibitor or with a combination of ATM and DNA-PKcs inhibitors, while the signal 
was still present when the cells had been pre-treated with the DNA-PKcs inhibitor alone 
(Figure 1E). Together, these data suggest that Mdc1 contains a conserved PIKK target site at 
its very N-terminus and that in response to IR, this site is a bona fide ATM target in vivo.  
 
The phosphorylated N-terminus of Mdc1 binds to its own FHA domain.  
To understand the functional implication of Mdc1 T4 phosphorylation, we carefully 
analyzed the amino acid sequence surrounding the PIKK target site. Besides the TQ motif, 
several additional amino acids are conserved, most notably an isoleucine three residues C-
terminal to the phosphoacceptor threonine. This is intriguing since pT-X-X-I was previously 
shown to constitute a favoured motif for certain classes of FHA domains (Durocher & 
Jackson, 2002). Indeed the entire N-terminal motif (M-E-D-pT-Q-A-I) closely resembles that 
derived for the Mdc1 FHA domain by oriented library screening in these studies. In order to 
test whether the phosphorylated N-terminus of Mdc1 could serve as a binding site for an FHA 
domain-containing proteins, we designed a phosphopeptide comprising the first 12 N-terminal 
residues of human Mdc1 phosphorylated on Thr-4. The phosphopeptide and its 
unphosphorylated derivative were coupled to magnetic beads and used to pull down proteins 
from Hela nuclear extracts. Both peptides retrieved several proteins that appeared as clear 
bands on a SDS polyacrylamide gel (Figure S2). Interestingly, at least three proteins were 
only pulled down by the phosphopeptide, but not by its unphosphorylated counterpart (Figure 
S2; highlighted by arrowheads). Most prominent were two bands of ~250kDa identified as 
Mdc1 itself as demonstrated by Western blot analysis with an antibody against human Mdc1 
(Figure 2A). The other two bands at ~150 kDa and ~80 kDa were RAD50 and MRE11, 
respectively. Together with our previous finding that Mdc1 exists in a complex with MRN in 
  Results
  77
Hela nuclear extracts (Goldberg et al, 2003; Spycher et al, 2008; Stucki et al, 2005), these 
results indicate that Mdc1 may be the predominant interaction partner of its own 
phosphorylated N-terminus.  
Of the two phosphospecific protein binding domains within Mdc1 (Figure 1A), 
phosphopeptide pull-down experiments with bacterially expressed GST fusion proteins of 
these regions showed that only the FHA domain bound tightly and specifically to the Mdc1 
N-terminal phosphopeptide, with no significant interaction detectable for the C-terminal 
BRCT-repeat region (Figure 2B). Furthermore, we were able to demonstrate high affinity 
binding of purified Mdc1 FHA to a synthetic phosphopeptide encompassing the Thr-4 motif 
by isothermal titration calorimetry (ITC). Interestingly, these data could only be satisfactorily 
fit using a binding model incorporating two independent phosphopeptide sites (Figure 2C; see 
below). Thus, these results establish that Mdc1 interacts directly with its own phosphorylated 
N-terminus via the N-terminal FHA domain and, additionally suggest that it does so in a 
manner that differs somewhat from pThr-dependent FHA interactions described previously. 
 
The Mdc1 FHA domain forms a dimer  
In order to characterize the Mdc1 FHA-pThr 4 interactions further, we determined the 
structures of both free and phosphopeptide-bound forms at high resolution by X-ray 
crystallography (Table S1). The pThr 4 phosphopeptide complex was solved using the single 
wavelength anomalous diffraction method with crystals grown from selenomethione-
substituted Mdc1 FHA domain, and a synthetic peptide in which Ala-6 was also replaced by 
selenomethionine, an approach we have described previously (Li et al, 2002). The refined 
coordinates of the complex were then used to solve the structure of the peptide-free form by 
molecular replacement. 
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As expected, the Mdc1 FHA domain adopts an 11-stranded !-sandwich fold that is 
characteristic of these signaling modules (Figure S3). Strikingly, we observed two FHA 
domains in the crystallographic asymmetric unit in both peptide-free and bound forms, each 
similarly arranged around a pseudo 2-fold non-crystallographic symmetry axis (Figure 3A; 
Figure S4). Although other FHA-FHA lattice interactions are observed in the two crystal 
forms, the non-crystallographic interaction surface is the most extensive burying a total of 
~900Å2/dimer in each case. Of these, ~600Å2 are contributed by non-polar atoms from the 
side-chains of Phe 37, Leu 101, Leu 120, Leu 122 and Leu 127, all highly conserved in 
available sequences of Mdc1 orthologues (Figure 3B). Together these residues from a 
hydrophobic cluster on one face of each FHA !-sandwich (Figure 3B) that is tightly packed 
with high surface complementarity at the FHA-FHA interface (Figure 3C).  
In the light of these observations, we examined the solution behaviour of the isolated 
FHA by size-exclusion chromatography and multi-angle laser light scattering (SEC-MALLS) 
that is able to conveniently measure shape-independent and highly accurate weight-averaged 
molecular weights of proteins and their complexes.  This analysis showed significant self-
association of the Mdc1 FHA domain with an apparent molecular weight of 18.3 +/- 0.06 
kDa, some 40% greater than the calculated monomer mass of 12.8 kDa (Figure 3D). 
Moreover, a double mutation, L122E/L127E, resulted in a significant reduction in apparent 
molecular weight (14.3 kDa; Figure 3D) presumably due to juxtaposition of repulsive charges 
at the interface. Thus, we conclude that the dimeric arrangement observed in the crystal 
structures is likely to be representative of the dimer we observe in solution.  
 
Thr-4 phosphorylation stabilizes a head-to-tail FHA interaction 
 The structure of the Mdc1 FHA/phosphopeptide complex (Figure 4A) shows a binding 
mode for the pThr 4 motif resembling that seen in several previously reported FHA domain 
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complexes. The phosphothreonine is held by a network of hydrogen-bonds with the highly 
conserved Arg-58 and Ser-72 side-chains along with accessory interactions with the less-well 
conserved Lys-73 (Figure 4B). Ile-7 occupies the pThr +3 position that has been shown to 
represent a major determinant of FHA specificity (Durocher et al, 2000) and interacts with the 
FHA domain through a shallow pocket formed by side-chains of residues 70, 96, 124 and 
125. Most intriguingly, Trp-9 that is present in all available sequences of Mdc1 orthologues, 
is the last peptide residue visible in electron density maps and packs into a cleft formed at the 
edge of the FHA-FHA interface. Here, the Trp-9 indole side-chain packs against Pro-103 and 
the aliphatic portion of Arg-102 from the second protomer, both highly conserved. Due to the 
fact that the local 2-fold symmetry is imperfect, the interactions of the non-crystallographic 
symmetry-related Trp-9 are still significant but less extensive, potentially explaining the two 
binding sites observed in ITC measurements. Regardless, the structural data strongly suggest 
that pThr motif binding might contribute to the overall stability of the dimeric complex and 
we investigated this idea further using SEC-MALLS (Figure 4C). While the FHA domain 
itself shows evidence of weak dimerisation as described above, addition of the pThr-4 peptide 
substantially increases the apparent weight-averaged molecular weight to within 92% of that 
calculated for a fully dimeric, peptide-bound complex. Consistent with the structural location 
of Trp-9 at the FHA-FHA interface, a peptide variant containing a W9A substitution results in 
almost no additional dimer stabilization. Thus, accessory interactions mediated by Trp-9 of 
the bound phosphopeptide seem to directly stabilize dimerisation of the Mdc1 FHA domain. 
These structural and hydrodynamic data reveal a novel dimeric FHA domain 
architecture that is stabilized through binding in trans to a motif representing the ATM-
phosphorylated Mdc1 N-terminal region. This suggested to us that Mdc1 dimerisation might 
occur in a head-to-tail fashion as has been proposed for the pre-activated state of ATM-
phosphorylated (pThr-68) Chk2 kinase (Li et al, 2008). Such a model is attractive since we 
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note that the conserved and highly acidic region (residues 10-18) C-terminal to Thr-4 could 
potentially interact with an equally conserved basic patch adjacent to the pThr-4 binding site 
but located on the adjacent protomer of the Mdc1 dimer (Figure 4D). Nonetheless, other 
arrangements are possible (Figure 4E). In particular the foregoing data did not eliminate the 
possibility of polymerization, nor did they exclude intra-molecular binding of the pThr-4 
motif to its own FHA domain, potentially disrupting the weakly associated solution dimer. 
The latter model is particularly relevant in the light of our recent data showing just such an 
intra-molecular regulatory association in the Rv1827 FHA-domain protein from M. 
tuberculosis (Nott et al, 2009). In order to distinguish between these possibilities, we sought 
to generate an intact Mdc1 N-terminal region containing pThr-4. Given the experimental 
difficulty in producing quantities of active, recombinant ATM sufficient for this type of 
biophysical analysis, we instead chose to employ expressed protein ligation technology to 
generate a specifically and stoichiometrically phosphorylated sample by a semi-synthetic 
route (Figure 4F - top panel). In doing so we noticed that Cys-26, which could potentially act 
as an N-terminal nucleophile, is located immediately C-terminal to Arg-25. Thus by limited 
proteolytic cleavage of Mdc1 (residues 1-138), we could generate a C-terminal FHA-
containing fragment with an N-terminal Cys-26. This, in turn, could be efficiently ligated to a 
pThr 4 phosphopeptide (residues 1-25) synthesized with a protected C-terminal thioester (Li 
et al, 2008). SEC-MALLS analysis of this material reported an apparent molecular weight of 
31.2 kDa, essentially identical to the expected dimeric mass of the phosphorylated fragment 
(31.110 kDa) (Figure 4F - bottom panel). Thus, we conclude that pThr-4 phosphorylation 
results in Mdc1 dimerisation through a Chk2-like head-to-tail mechanism. Furthermore, the 
lack of any observable dissociation of this species at an on-column peak concentration of ~8 
µM, also suggests that the phospho-dependent dimeric association occurs with high affinity. 
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Mdc1 self-association in human cells is pThr-4-dependent 
Our in vitro data clearly demonstrate head-to-tail dimerization of the Mdc1 FHA 
domain via phosphorylation-dependent interactions with its N-terminal region. We next 
addressed the question whether this mode of interaction also occurs in cells. To do this, we 
first set up an experimental system that allowed the detection of interaction between different 
Mdc1 molecules by co-immunoprecipitation. As shown in Figure 5A, a Flag-tagged Mdc1 
fragment (1-800) efficiently interacted with an identical Myc-tagged fragment. We used an N-
terminal fragment lacking the BRCT domains to avoid problems with extraction due to avid 
association of Mdc1 with DNA damage-induced chromatin. Surprisingly, interaction between 
the two fragments was not dependent on IR treatment. However, when we probed the 
membranes with the pT4 antibody, we noticed that transiently expressed Mdc1 (1-800) 
fragment was constitutively phosphorylated on Thr-4 even without prior irradiation of the 
transfected cells (data not shown). This is probably due to the transfection procedure that has 
previously been shown to lead to constitutive phosphorylation of ATM targets. Nevertheless, 
mutation of either the FHA domain (R58A) and of the phosphoepitope (T4A) led to a 
significant reduction of the interaction between Flag-tagged and Myc-tagged Mdc1 (1-800). 
Concomitant mutation of both the FHA domain and Thr-4 resulted in a complete loss of the 
interaction, indicating that when expressed in human cells, the mechanism of Mdc1 
dimerization is similar to the one observed in our in vitro binding experiments and crystal 
structures. 
 
Mdc1 dimerization mediates recruitment of the FHA domain to sites of DNA damage 
Next, we sought to demonstrate Mdc1 dimerization in living cells. We reasoned that if 
DNA damage-induced Mdc1 dimerization occurs via the FHA domain, we should detect 
partial recruitment of the FHA domain to sites of DSBs through association with endogenous 
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Mdc1. Moreover, this recruitment should be diminished by mutations in either the FHA 
domain or at the pThr-4 site. To circumvent limitations of the static assessment of IRIF 
formation in fixed cells, we used a previously described integrated imaging unit that 
combines microlaser-assisted generation of spatially defined DSB areas in mammalian cells 
with rapid, continuous and interactive image acquisition (Lukas et al, 2003; Lukas et al, 
2004). Since we and others have previously observed that over expression of the Mdc1 FHA 
domain interferes with accumulation of DDR proteins (including Mdc1 and the 
Mre11/Rad50/Nbs1 complex) at sites of DSBs (Dimitrova & de Lange, 2006; Goldberg et al, 
2003; Xu & Stern, 2003), we also generated a panel of cell lines derived from checkpoint-
proficient U2OS cells carrying stably integrated, tetracycline-regulated expression cassettes 
directing the expression of the Mdc1 FHA domain fused to enhanced yellow fluorescent 
protein (EYFP). Significantly, when expressed at low levels, the Mdc1 FHA domain is 
recruited to microlaser-induced DNA damage (Figure 5B). The real-time measurements 
revealed a rapid accumulation of the fusion protein around the laser-generated, DSB-
containing, subnuclear tracts (Figure 5C). The increase in fluorescence in the damaged 
nuclear compartments became detectable within 20-30 s (Figure 5C, first panel). 
Subsequently, the fusion protein underwent a rapid accumulation in the DSB regions, and 
reached a steady-state by 8-10 minutes after laser exposure. Importantly, no increase in 
fluorescence was observed in DSB-containing laser tracks in Mdc1-depleted cells, indicating 
that EYFP-FHA domain accumulation is strictly Mdc1-dependent (Figure 5D). Moreover, no 
accumulation was detectable in cells that express T4A or the R58A and L120/127E mutant 
derivatives of the FHA domain (Figure 5E). Thus, these data reveal that FHA accumulation to 
microlaser-induced DNA damage in living human cells mirrors the in vitro requirements for 
Mdc1 dimerization, strongly supporting the notion that Mdc1 dimerization in response to 
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DNA damage also occurs in vivo and that is does so in a manner that is consonant with our 
structural data. 
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Discussion 
 
Mediator proteins such as Mdc1, Brca1 and 53BP1 play a variety of roles in the DDR. 
Phospho-dependent binding function is common to all, and all contain at least one domain 
capable of this function but interacting partners are not always clear. Oligomerisation now 
appears to be central to mediator activity and 53BP1, along with budding yeast Rad9 and 
fission yeast Crb2 have all been shown to self-associate albeit through different structural 
mechanisms. Rad9 seems to oligomerise via BRCT interactions with phosphosites generated 
by the ATR orthologue, Mec1, in a process that promotes activation of the Rad53 checkpoint 
kinase (Soulier & Lowndes, 1999; Usui et al, 2009). In contrast Crb2 and 53BP1 dimerisation 
appear to be independent of any post-translational modification (Kilkenny et al, 2008; Zgheib 
et al, 2008). To date, the oligomeric status of Mdc1 has not been examined. Here, we present 
a molecular description of FHA-mediated Mdc1 dimerisation in response to ATM 
phosphorylation of a specific and novel N-terminal motif.  
 
A general role for dimerisation in FHA domain signaling 
Our observation of phospho-independent FHA dimerisation is intriguing. Since their 
discovery as a conserved motif in forkhead transcription factors (Hofmann & Bucher, 1995), 
numerous x-ray crystallographic and NMR structures of different FHA domains have been 
described (Mahajan et al, 2008) but no structure of a dimeric FHA has yet been reported . 
Intriguingly, evolutionary trace analysis has been used to identify a novel patch of low-level 
sequence conservation associated with !-strands 9 and 10 and the connecting loop, leading to 
the suggestion that this may act as a self-interaction surface (Lee et al, 2003). Intriguingly our 
structure now shows that this putative surface substantially overlaps with the Mdc1 dimer-
forming region (Figure S5). Moreover we also show that mutations within this region disrupt 
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FHA-FHA interactions in vitro (Figure 3D) and in living human cells (Figure 5E).  These 
data, together with our recent observation that a similar region of a mycobacterial FHA 
domain mediates phospho-independent intermolecular interactions with several physiological 
targets (Nott et al, 2009), suggest a more expansive role for the !-sandwich architecture in 
FHA binding than has previously been assumed. 
 
Dimerisation as a regulator of Mdc1 FHA interactions 
While the "H2AX-binding function of the BRCT-repeat of Mdc1 is clear (Stucki et al, 
2005), the in vivo role of the FHA domain is more enigmatic. Therefore, our observation that 
a major binding partner for the Mdc1 FHA domain is Mdc1 itself is intriguing and provides 
for means of both positively and negatively regulating FHA activity (Figure 6). As an 
example, Chk2 binding has been suggested to involve interaction of pThr-68, a major site of 
ATM-phosphorylation in the Chk2 SQ/TQ region, with the Mdc1 FHA domain (Lou et al, 
2003b). We have recently shown that a tight pThr-68-dependent head-to-tail dimerisation of 
Chk2 results in effective occlusion of the canonical phospho-interacting FHA surfaces and 
prevents interactions of the pThr-68 motif with the Mdc1 FHA (Li et al, 2008). Clearly, our 
new data show that a similar effect would be expected for the pThr-4 Mdc1 FHA dimer. 
However, we and others have also shown that autophosphorylation of the Chk2 FHA releases 
monomeric Chk2 (Ahn & Prives, 2002; Li et al, 2008). This, in turn, would expose the pThr-
68 motif and, potentially, allow binding to Mdc1 FHA domain prior to Thr-4 
phosphorylation. ATM phosphorylation of Thr-4 and ensuing Mdc1 FHA dimerisation would 
then release Chk2, potentially explaining the observation of ejection of activated forms of 
Chk2 from chromatin fractions soon after DNA-damage (Li et al, 2008). Such a 'bind-and-
release' mechanism could, in principle, operate for any interaction partner containing a 
suitable pThr-containing motif (Figure 6A). Similarly, formation of the tight, ATM-dependent 
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Mdc1 dimer would also occlude the FHA-FHA interaction surface that could function as a 
phospho-independent binding region (Figure 6B). Indeed, and as mentioned above, we have 
recently shown that part of this FHA domain surface can function in just such a fashion in 
other signaling contexts (Nott et al, 2009). Alternatively, we surmise that Mdc1 dimerisation 
might create new phospho-independent surfaces spanning both FHA domains (Figure 6C) and 
note that such an extensive, negatively charged surface is evident in our crystal structures 
(Figure S6). 
 
An architectural role for Mdc1 dimers? 
From an architectural viewpoint, a major effect of Thr-4 phosphorylation would be to 
stabilize formation of a large (~4000 aa) dimeric Mdc1 scaffold. Such a molecule would have 
the potential to bridge large distances in chromatin distal to DNA-break sites through !H2AX 
interactions with the BRCT-repeat domains at either end. Although the major means by which 
broken DNA ends are maintained in proximity for efficient repair is through the bridging 
function of the MRN complex (Williams et al, 2008), it may be that Mdc1 dimers play a 
contributing role in stabilizing more global structure within chromatin loops containing 
damage sites (Bassing & Alt, 2004). Indeed, the dependence on Mdc1 for rapid repair of 
dysfunctional telemores (Dimitrova & de Lange, 2006) suggests that such a tethering function 
may contribute to telomere maintenance and other NHEJ-mediated processes. Lastly, the 
existence of two BRCT-repeat domains within the Mdc1 dimer, and the significant effects of 
Mdc1 loss on fertility and spermatogenesis may be indicative of a bridging role in meiotic 
crossover events where Spo11-mediated dsDNA breaks sponsor accumulation of !H2AX 
binding sites for Mdc1 within each recombining homologue. In this context, it is interesting to 
note that Mdc1 mutants lacking the FHA domain were unable to complement the homologous 
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recombination defect observed in mouse embryonic fibroblasts derived from Mdc1 knockout 
animals (Xie et al, 2007). 
 
Concluding remarks 
Our data present compelling evidence for DNA-damage dependent Mdc1 dimerisation 
both in vitro and in vivo and suggest a number of ways in which this phenomenon might 
contribute to its activities in the DDR. Ultimately, unraveling the functional and mechanistic 
roles of the Mdc1-Mdc1 interactions reported here will require further investigation. 
However, our data now provide a firm structural and mechanistic framework for future 
analysis of this important and complex molecule. 
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Materials & Methods 
 
Plasmids 
Human MDC1-GST constructs were previously described (Spycher et al, 2008) 
Human MDC1 (aa 1-800) was generated by PCR and C-terminally tagged with HA/FLAG 
and Myc, respectively, and cloned into pcDNA3.1 (+) mammalian expression vector 
(Invitrogen). The MDC1 FHA domain (aa 1-154) was amplified by PCR and cloned into a 
modified pEYFP-nuc vector (Clontech), in which two tetracycline-repressor binding elements 
were inserted between promotor and coding sequences to generate an inducible expression 
cassette (Stucki et al, 2005). Point mutations were introduced by PCR-based methods or using 
the QuikChange Site-Directed Mutagenesis kit (Stratagene).  
 
Protein expression and purification 
DNA fragments encoding human Mdc1 residues 1-138 or 27-138 were amplified from 
a Mdc1 cDNA clone and ligated into BamH1/Xho1 digested pGEX-6P1. GST fusion proteins 
were affinity purified on glutathione-4B resin (Amersham) and cleaved from the affinity resin 
with rhinovirus 3C protease overnight at 4°C. Cleaved Mdc1 fragments were concentrated to 
~ 5mg/ml and purified by gel-filtration chromatography on Superdex 75 in 20mM Tris-HCl 
pH 8.3, 150 mM NaCl, 5 mM DTT.  
 
Crystallisation and X-ray data collection 
Crystals of peptide-free Mdc1 (27-138) were grown by microbatch methods under Al's 
oil at 18°C at a protein concentration of 10 mg/ml mixed with an equal volume of 1.32 M 
ammonium sulphate, 50 mM sodium acetate pH 4.6 and 5% v/v methyl-pentanediol. Complex 
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crystals were grown from 1:1 complexes of selenomethionine substituted Mdc1 (27-138) with 
pThr-4 peptide containing a selenomethionine substituent at the pT+2 position, at a 
concentration of 15 mg/ml, mixed with an equal volume of 25% v/v ethanol, 0.1 M sodium 
acetate pH 5.5. Crystals were cryo-protected in mother liquor supplemented with 25% v/v 
glycerol (peptide-free) or 17.5% v/v ethylene glycol/10% v/v ethanol prior to data collection.  
 
Structure solution and refinement 
The structure of the selenomethionine peptide complex was solved by the single-
wavelength anomalous diffraction (SAD) method using data collected on beamline 10.1 at the 
SRS Daresbury, UK. Four selenium sites were located and phases refined by 
SOLVE/RESOLVE (Terwilliger & Berendzen, 1999). The resulting map was readily 
interpretable allowing an essentially complete model for the two complexes in the asymmetric 
unit. The resulting FHA domain structure was then used to solve the non-complexed crystal 
form by molecular replacement using PHASER (McCoy et al, 2007). Model-building was 
carried out with 'Coot' (Emsley & Cowtan, 2004) and both structures were refined using 
REFMAC5 (Murshudov et al, 1997). 
 
Cell culture and gene transfer 
MDC1
-/-
 and MDC1
+/+
 MEFs were gifts from J. Chen (Yale University, New Haven, 
CT). U2OS, HEK 293T and MEFs were grown in D-MEM (Invitrogen) supplemented with 
10% FCS (Gibco) and streptomycin/penicillin (100 U/ml, Gibco). Transfection of plasmids 
was done using either FuGene 6 (Roche) or Calcium phosphate. U2OS-TetOn cells stably 
expressing the tetracycline repressor were generated by transfection of EYFP-tagged MDC1-
FHA domain following selection in G418-containing medium (Calbiochem). The siRNA 
oligonucleotides against endogenous human MDC1 were purchased from Ambion (siRNA 
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ID: 21738) containing the following sequence: sense 5’-GGAUCACACAAAGAUUAGAtt 
and antisense 5’-UCUAAUCUUUGUGUGAUCCtt. SiRNA transfections were performed 
using Lipofectamine RNAiMAX (Invitrogen) according the manufacturer’s protocol. DNA 
damage was induced in a Faxitron X-ray cabinet at 5-10 Gy/min. or by means of single-cell 
laser microirradiation (see below). 
 
Antibodies  
The mouse monoclonal !H2AX antibody was obtained from Millipore and the rabbit 
polyclonal c-Myc antibody (sc-789) from Santa Cruz Biotechnology. The rabbit polyclonal 
FLAG antibody and the ANTI-FLAG M2 affinity gel, used for co-immunoprecipitation, were 
purchased from Sigma. Rabbit Polyclonal MDC1(889) and sheep polyclonal MDC1(3835) 
antibodies were raised against MDC1-FHA–GST as described previously (Goldberg et al., 
2003). The phosphospecific antibody MDC1 pT4 was raised in rabbit against the 
phosphopeptide MEDT(P)QAIDWDVC and affinity purified using the phosphorylated and 
non-phosphorylated peptide (Eurogentec). Rabbit polyclonal ATM antiserum for ATM 
immunoprecipitation was a kind gift from Graeme Smith (KuDOS Pharmaceuticals, 
Cambridge, UK). 
 
Biochemical analysis 
Hela nuclear extract was purchased from Cilbiotech (Mons, Belgium). MDC1-GST 
fragments were affinity purified on Glutathione-Sepharose (GE Healthcare Biosciences) as 
described previously (Spycher et al, 2008). For peptide pull down analysis, the C-terminally 
biotinylated phosphopeptide MED[pT]QAIDWDAE[KBtn] (Sigma) was used. Where 
indicated, 25 nmol of the peptide were pre-incubated with 100 U "!PPase (New England 
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BioLabs) at 30°C for 20 min. Peptide pull down analysis was done as described (Stucki et al, 
2005). 
For in vitro ATM kinase assays, ATM was immunoprecipitated with a rabbit polyclonal ATM 
antiserum (Hickson et al, 2004) from HeLa nuclear extract (Cilbiotech) in IP buffer (25 mM 
Hepes pH 7.4, 250 mM KCl, 2 mM MgCl2, 10% glycerol, 0.1% NP-40, 0.5 mM EDTA, 1 
mM NaF, 1 mM !-glycerophosphate). The immunocomplex was subsequently bound to 
Protein A-Sepharose beads (GE Healthcare). The kinase assay was performed by adding 1 !g 
GST-MDC1 (aa 1-154) to the beads in ATM-kinase buffer (50 mM Hepes pH 7.4, 150 mM 
NaCl), 4 mM MnCl2, 6 mM MgCl2, 10% glycerol, 1 mM DTT, 1 mM NaF, 1 mM !-
glycerophosphate, 0.5 mM ATP and 10 !Ci "-[32P]ATP) and incubating for 30 min at 30°C. 
Reactions were stopped by boiling in SDS sample buffer and run on an SDS polyacrylamide 
gel. Gels were analyzed by autoradiography and GelCode Blue Stain Reagent (Pierce) or 
Coomassie blue staining. 
ATM inhibitor KPL0064 and DNA-PK inhibitor NU7026 were a kind gift from Graeme 
Smith (KuDOS Pharmaceuticals, Cambridge, UK) and were used at 10 !M and 20 !M, 
respectively. 
 
Expressed protein ligation 
Purified Mdc1 1-158 was digested with trypsin (Promega) at a ratio of 1:250 w/w 
enzyme:substrate to yield a 112 residue fragment (26-138) containing the FHA domain and 
part of the preceding linker with Cys-26 at its N-terminus. Synthesis of a C-terminally 
protected pThr-4 peptide (MEDpTQAIDWDVEEEEETEQSSESLR-SBn) and in vitro 
ligation to the Mdc1 26-138 fragment were carried in 200 mM phosphate buffer pH 8.0, 150 
mM NaCl, 10mM TCEP, 2% w/v 2-mercaptoethanesulphonic acid (MESNA) overnight at 
room temperature as described previously (Li et al, 2008). 
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SEC-MALLS 
Samples were applied at a concentration of 80-100 µM to a Superdex 75 10/300 GL 
column mounted on a Jasco HPLC and equilibrated in 20 mM Tris-HCl pH 8.3, 150 mM 
NaCl 3 mM DTT at a flow rate of 0.5 ml/min. Scattered light intensities of the column eluate 
were recorded at sixteen angles using a DAWN-HELEOS laser photometer (Wyatt 
Technology Corp., Santa Barbara, CA) and protein concentration of the eluted peak fractions 
were determined from the refractive index change (dn/dc = 0.186) using an OPTILAB-rEX 
differential refractometer equipped with a temperature-regulated flow cell at 25°C. The 
weight-averaged molecular weights of proteins and complexes within the elution peaks were 
determined using the ASTRA software version 5.1 (Wyatt Technology Corp., Santa Barbara, 
CA).  
 
Isothermal titration calorimetry 
ITC was carried out using a VP-ITC calorimeter (MicroCal, USA). Protein and 
peptides were desalted by dialysis or gel-filtration into a buffer containing 20 mM Tris-HCl 
pH 8.3, 150 mM NaCl, 0.5 mM TCEP. Typically, 10 µl aliquots of peptide at a syringe 
concentration of x mM were titrated over 30 injections into Mdc1 FHA domain samples at a 
concentration in the ITC cell of x µM using an integration time of 5 minutes. Data were 
corrected for heats of dilution and analysed using the Origin 5.0 software supplied with the 
instrument. Phosphopeptides were synthesized by Dr. W. Mawby (University of Bristol, UK). 
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Co-Immunoprecipitation  
HEK 293T cells were transiently co-transfected with pcDNA3.1-MDC1(800)-FLAG 
and pcDNA3.1-MDC1(800)-Myc or the T4A, R58A, T4A/R58A mutants respectively using 
calcium phosphate. 48 h later, cells were mock- or IR-treated with 10 Gy. After 45 min, cells 
were lysed in NP-40 buffer (50 mM Hepes-KOH pH 7.9, 100 mM NaCl, 1mM EDTA, 1mM 
DTT, 0.5 % NP-40, 20% glycerol, PMSF, Leupeptin, Pepstatin A, Bestatin, 10 MM !-
glycerophosphate and 1 mM NaF) for 15 min at 4°C and subsequently centrifuged at 14 000 
rpm for 30 min at 4°C. Proteins in the supernatant were immunoprecipitated with ANTI-
FLAG affinity gel (Sigma) in IP-buffer (see NP-40 buffer, but use of 40 mM Hepes-KOH pH 
7.4, 0.05 % NP-40, no glycerol, no DTT) for 4h at 4°C. Immunocomplexes were washed 
three times in IP-buffer, boiled in SDS sample buffer and loaded on an SDS-polyacrylamide 
gel. Protein analysis was performed with standard immunoblot methods as described above. 
 
Microirradiation and single-cell analysis 
In order to generate DSBs in defined nuclear volumes laser microirradiation was 
performed with a MMI CELLCUT system containing a 355 nm UVA laser (55 Hz, Molecular 
Machines & Industries, Switzerland) coupled to an Olympus IX71 microscope station and 
focused through an LUCPLFLN 40X objective. The MMICELLTOOLS software with 
MMIUVCUT plug-in assisted the laser operation using an energy output of 55% (unless 
stated otherwise). Prior to laser irradiation, cells were grown on coverslips in cell culture 
dishes in the presence of 10 µM BrdU (Bromodeoxyuridine; Sigma) for 24 h. Expression of 
EYFP-MDC-FHA constructs in U2OS-TetOn cells was induced for 0.5 – 2 h with 1!g/ml 
Doxocyclin. Coverslips were then transferred into LabTek chamber slides (Nunc) and 
mounted on the microscope stage for irradiation. After irradiation, cells were placed back in 
the incubator for 30-60 min before fixation.  
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In case of live cell imaging, EYFP-MDC1-expressing cells were directly grown on LabTek 
chamber slides in the presence of 10 µM BrdU for 24 h. Laser irradiation was performed with 
a 337 nm PALM microlaser workstation (30 Hz, Palm MicroBeam, Carl Zeiss Microimaging 
Inc.) mounted on an Axiovert 200 microscope (Zeiss) and focused through a LD 40x, NA 0.6 
Zeiss Achroplan objective. The microlaser procedure was assisted by the PALMRobo-
Software. Images were immediately recorded after laser treatment. 
For immunofluorescence analysis, cells grown on coverslips were fixed in 4 % 
paraformaldehyde for 20 min and permeabilized in 0.25 Triton X-100 in PBS for 15 min. 
After blocking in 10% FCS/PBS, cells were incubated in 5% FCS/PBS with the indicated 
primary antibodies for 1 h and secondary antibodies Alexa Fluor 568 (Molecular Probes) or 
Texas Red (Jackson Immuno Research) for 30 min. Finally, the coverslips were mounted with 
DAPI-containing Vectashield (Vector Laboratories). Confocal image acquisition was 
performed on a Leica SP2 microscope with a 40 x (NA 1.25) oil immersion objective or on an 
LSM-510 (Carl Zeiss Imaging) microscope with a 40 x Plan-Apochromat (NA 1.3) oil 
immersion objective. 
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Figure legends 
 
Figure 1 - ATM targets Mdc1 on a conserved threonine residue at its N-terminus.  
A - In vitro ATM kinase assay of recombinant Mdc1 fragments. Top: Schematic 
representation of Mdc1’s domain architecture and of the GST-fusion fragments derived from 
its cDNA. Bottom: Upper panel: Coomassie blue stained polyacrylamide gel of the purified 
GST-fusion fragments. Bottom panel: Autoradiography of in vitro phosphorylated Mdc1 
fragments 
B - A conserved motif at the very N-terminus of Mdc1 is phosphorylated by ATM in vitro. 
Top: Sequence alignment of the Mdc1 N-terminus. The highly conserved Thr residue at 
position 4 (T4) is highlighted by an arrowhead. Bottom: ATM-phosphorylation of fragment 
M-1 and the mutant T4A. AR: Autoradiograph; CB: Coomassie blue; IB: immunoblot; PS: 
Ponceau red 
C - Left panel: Dose titration using the pT4 phosphospecific antibody (!-pT4). Right panel: 
Kinetics experiment using the pT4 phosphospecific antibody. The band corresponding to 
Mdc1 is highlighted by an arrowhead. 
D - Mdc1
+/+
, Mdc1
–/–
 MEFs were irradiated with various doses of IR. Extracts were probed 
with the pT4 antibody. 
E - Mdc1 Thr-4 phosphorylation in response to IR is ATM-dependent. U2OS cells were pre-
treated with ATM inhibitor, DNA-PKcs inhibitor or a combination of both inhibitors. Cell 
extracts were probed with the phosphospecific pT4 antibody. 
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Figure 2 - The phosphorylated Mdc1 N-terminus constitutes a recognition motif for the 
Mdc1 FHA domain. 
A - The N-terminal Mdc1 pThr-4 sequence closely resembles the optimal binding motif 
derived previously {Durocher, 2000 p00534} by oriented peptide library selection. Circled 
residues highlight exact matches. 
B - Immunoblot analysis indicates that endogenous Mdc1 is efficiently pulled down by the T4 
phosphopeptide. 
C - Coomassie blue-stained PAGE of a Thr-4 phosphopeptide pull-down experiment using 
purified M-1 GST-fragment (containing the FHA domain) and purified M-8 GST-fragment 
(containing the BRCT domains). 
D - ITC binding isotherm for interaction of a synthetic pThr-4 peptide with recombinant 
Mdc1 FHA domain. Data were analysed assuming one or two site binding which consistently 
favoured the latter model, showing tight, stoichiometric (1:1) binding to similar but non-
identical sites. 
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Figure 3 - Mdc1 FHA domain dimerisation 
A - Ribbons reporesentation of the dimeric arrangement observed in the peptide-free Mdc1 
FHA crystal structure. The position of the local 2-fold symmetry axis is indicated. All 
structural representations were generated using PyMOL (http://pymol.sourceforge.net/). 
B - FHA-FHA interactions are predominantly medited by a conserved cluster of hydrophobic 
residues (top) that are highly conserved in all available sequences of Mdc1 orthologues 
(bottom). The location of !-strands observed in the structure are indicated in the lower panel, 
along with the positions of the four residues most highly conserved in the FHA domain family 
(circles). 
C - SEC-MALLS analysis of the wild-type Mdc1 FHA (27-138) and a mutant form in which 
two residues that form the core of the observed dimer interface have been substituted with 
glutamate. The observed weight-avereaged molecular weight of the mutant is substantially 
less than the wild-type protein. The shorter retention time for the mutant may reflect a more 
extended shape for monomeric forms, or differential electrostatic effects on interaction with 
the column matrix. 
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Figure 4 - Head-to-tail dimerisation is stabilised by pThr-4  
A - Structure of the Mdc1/pThr-4 peptide complex is shown as a Ca plot/surface 
representation with the peptide shown as sticks, viewed along the local 2-fold symmetry axis. 
B - The phosphopeptide interacts with conserved FHA domain residues mainly through pThr-
4 and main-chain atoms from pT+1 and +3 residues. The Trp-9 indole nestles in a cleft 
formed at the interface between the two FHA domains in the dimer. 
C - SEC-MALLS analysis shows that a substantial stabilization of the Mdc1 FHA dimer by 
the pThr-4 peptide is greatly reduced by substitution of Trp-9 with alanine (W9A). 
D - The sequence C-terminal to the pThr-4 motif (yellow) contains a highly conserved stretch 
of acidic residues highlighted in blue (top panel). These would be predicted to interact with 
arginine and lysine residues that are also conserved and form a basic patch adjacent to the 
binding site for the peptide C-terminus of the bound peptide (bottom). 
E - Cartoon showing the three most likely effects of Thr-4 phosphorylation 
F - Ligation of an extended pThr-4 peptide to trypsin-cleaved Mdc1 FHA (left) produces a 
stoichiometrically and specifically phosphorylated protein encompassing the entire N-
terminal region that forms a tight dimer by SEC-MALLS analysis (right). Mo- observed 
molecular weight, Mc - calculated molecular weight. 
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Figure 5 - Dimerization of the Mdc1 N-terminal region in vivo 
A - The interaction between differentially tagged Mdc1 N-terminal fragments is dependent 
upon the intact FHA domain and Thr4 phosphorylation. 293T cells were transiently 
transfected with Flag-tagged Mdc1(1-800aa) and Myc-tagged Mdc1(1-800aa) wildtype and 
the indicated mutants, respectively. Protein complexes were immunoprecipitated with 
monoclonal anti-Flag agarose and immunoblotted with polyclonal anti-Myc and polyclonal 
anti-Flag antibodies. 
B - The Mdc1 FHA domain is recruited to damaged chromatin regions. U2OS expressing a 
tetracycline-inducible EYFP-FHA(WT)
TetOn
 fusion protein were treated with doxocyclin for 2 
hours and subjected to laser irradiation. Cells were fixed 30 min after irradiation and 
immunostained for !H2AX.   
C - Kinetics of Mdc1 FHA domain recruitment. U2OS FHA(WT)-EYFP
TetOn
 cells were 
incubated with doxocyclin for 1h and subjected to laser irradiation. Time lapse live cell 
microscopy was performed and images were taken at the indicated times. Note that for 
technical reasons, 0 min time point was taken about 20 sec after micro-irradiation. 
D - Recruitment of Mdc1 FHA domain is dependent on endogenous Mdc1. U2OS 
FHA(WT)EYFP
TetOn
 cells were either treated with control siRNA or siRNA against 
endogenous Mdc1. Cells were induced with doxocyclin for 1h, subjected to laser irradiation 
and images were taken 30 min thereafter. Cells were subsequently fixed and immunostained 
for !H2AX.  
E - Recruitment of Mdc1 FHA domain is dependent on phospho-specific interaction between 
Thr4 and the FHA domain as well as on an intact hydrophobic interface between FHA 
monomers. Doxocyclin induced U2OS FHA-EYFP
TetOn
 cells expressing the wild type and 
indicated mutants were induced with doxocyclin for 1h, subjected to laser irradiation and 
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images were taken 30 min thereafter. Cells were subsequently fixed and immunostained for 
!H2AX.  
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Figure 6 - Regulation of interactions through phospho-dependent and phospho-
independent surfaces through ATM-dependent Mdc1 dimerisation.  
A - Binding of Thr-phosphorylated partners such as Chk2 (gold) can occur through the 
canonical phospho-dependent surface on the Mdc1 FHA (green patch) that is subsequently 
occluded following Thr-4 phosphorylation and tight head-to-tail dimerisation. 
B - Interaction of phospho-independent binding partners (red) with some or all of the Mdc1 
dimerisation interface residues (yellow) competes with weak FHA-FHA interactions in un-
phosphorylated Mdc1, but is occluded in the pThr-4 dimer. 
C -Tight Mdc1 dimerisation might create a contiguous phospho-independent binding surface 
(cyan) spanning the two FHA domains. 
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Supplementary information 
 
Molecular basis of ATM and FHA-dependent Mdc1 dimerisation in 
response to DNA-damage 
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Figure S1 – Autoradiography of in viro-phosphorylated N-terminal MDC1 fragment 
comprising the FHA domain. In this fragment, two ATM/ATR consensus sites (TQ) are 
present (T4 and T98). However, only T4 is phosphorylated by ATM in vitro since M1 (!N) 
lacking the N-terminal T4 is not phosphorylated.  
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Figure S2 - Silver-stained SDS PAGE gel of proteins pulled down by the Thr-4 
phosphopeptide and its unphosphorylated derivative. The major bands present only in the 
phosphopeptide pull-down are highlighted by arrowheads.  
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Figure S3 - Comparison of the Mdc1 FHA structure with that of human Chk2 (PDB ID: 
1GXC) reveals a similar, characteristic core FHA domain !-sandwich architecture. 
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Figure S4 - Least-squares superposition of the Mdc1 FHA domain dimer in the peptide-free 
(black) and pThr-4 peptide-bound (gold) structures, shown as C! plots. The bound 
phosphopeptide is shown in stick representation. 
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Figure S5 - Topology diagram (left panel) and surface representation (right panel) show that 
hydrophobic residues that form the conserved Mdc1 FHA-FHA interface (red circles) overlap 
with a putative self-interacting surface (blue) previously identified by sequence analysis.  
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Figure S6 - Electrostatic surface representation of the Mdc1 FHA dimer viewed along the 
non-crystallographic 2-fold axis. Regions of positive potential are shown in blue and acidic 
regions in red. Association of the two FHA domains produces a continuous region of negative 
charge that extends across the dimer. 
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Table S1 - Crystallographic Statistics 
 Mdc1-pT4 (SeMet) Mdc1 
   Space group P212121 P21 
   Unit cell (Å) a = 58.5, b = 59.9, c = 72.1 a = 55.2, b = 64.9, c = 106.4, 
! = 96.1° 
   Number of molecules/au  2 2 
   Wavelength (Å) 0.9790 0.9757 
   Resolution (Å) 15.0 – 1.8 (1.86-1.80) 20.0 – 2.3 (2.40-2.30) 
   Completeness (%) 93.4 (55.3) 94.5 (66.5) 
   Total observations 134542 113597 
   Unique observations 42419 30800 
   Redundancy  3.2 (2.1) 3.7 (3.0) 
   Rmerge
a (%) 3.7 (31.5) 7.0 (40.4) 
   < I/! (I) > 27.5 (2.1) 14.9 (2.7) 
Structure Solution   
Phasing method SAD Molecular replacement 
Selenium sites / molecule 2  
Refinement   
   Resolution (Å) 15 – 1.8 15.0 - 2.3 
   R (%)b 21.3  
   Rfree (%) 24.0  
   r.m.s.d. bond lengths (Å2) 0.008  
   r.m.s.d. bond angles (°) 1.2  
   Ramachandran plot   
      Preferred regions (%) 97.0  
      Allowed regions (%) 3.0  
      Outliers (%) 0.0  
 
a 
Rmerge = "h"i|Ih,i – <Ih>|/ "h"iIh,i, where Ih,i is the intensity of the individual reflections and  <Ih> 
is the mean intensity over symmetrically equivalent reflections 
b
 R = "h||Fo,h| - |Fc,h||/"h|Fo,h|, where |Fo,h| and |Fc,h| are observed and calculated structure 
factor amplitudes, respectively; Rfree was calculated with 5% of the data. 
 
 

6 Discussion
6.1 The interaction between MDC1 and the MRN complex
6.1.1 Summary of own findings
We identified a region in MDC1 that is essential for efficient recruitment and 
accumulation of the MRN complex in chromatin compartments flanking sites of DSBs. This 
region contained a repeated acidic sequence motif (the SDT motif) that was constitutively 
phosphorylated by the acidophilic kinase CK2 on highly conserved Ser and Thr residues. 
We presented evidence that the doubly phosphorylated SDT motifs regulate accumulation 
and retention of the MRN complex in DSB-flanking chromatin regions. This retention of 
MRN involves direct interaction of the NBS1 N-terminal FHA and BRCT domains with the 
SDT motifs of MDC1. In addition, CK2 was essential for NBS1 accumulation in damaged 
chromatin and depletion of CK2 disrupted the MDC1-MRN complex in vivo. The analysis of 
different mutants  of NBS1 in complemented NBS cell lines showed that the FHA as well as 
the BRCT domain of NBS1 are important for efficient retention of the protein to DSB-
flanking chromatin regions. Finally, we observed a defect in G2/M-checkpoint activation at 
low doses of irradiation in a NBS cell line complemented with a FHA mutant of NBS1 
protein that was defective in MDC1 binding but not with a BRCT mutant that was also 
defective for MDC1 binding.
6.1.2 The MDC1-MRN complex in the DNA damage response
One of the most important roles of the MRN complex in the DNA damage response is 
its implication in sensing of DSBs and thereby initiating the DNA damage signaling cascade 
by recruiting ATM to sites of DSBs and participating in its activation. Our recent findings of 
the MDC1-MRN complex formation imply that the MRN complex has an additional function 
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in the amplification of the DNA damage signal and the establishment of the IRIF 
compartment surrounding the break. Interestingly, it was previously reported that MDC1 
and the MRN complex interacted already in unstressed cells (Goldberg et al., 2003; Stewart 
et al., 2003). We and others  confirmed these findings and showed in addition, that complex 
formation is mediated by the constitutively active casein kinase 2 (This thesis chapter 5.1 
and (Melander et al., 2008; Wu et al., 2008)). There are at least two possible reasons  for 
this  ‘pre-formation’ of the complex. First, the recruitment of the MRN complex to the DSB 
flanking chromatin may be faster if it is not dependent on events  that happen after the break 
occurs. Second, the MDC1-MRN complex may have a physiological role beyond the DDR. 
MDC1 is known to be chromatin bound even in the absence of DNA damage. Therefore, 
MDC1 along with the MRN complex may play a role in chromatin organization also in the 
absence of DNA damage, e.g. during normal DNA replication or in mitosis. It should be 
mentioned at this point that the interaction between MDC1 and the MRN complex is  very 
dynamic in living cells and no stable holocomplex seems to exist. Evidence for this came 
from measurements of NBS1 and MDC1 mobility in living cells, that showed that the 
residence time of MDC1 at DSBs is almost one order of magnitude longer compared to 
NBS1 (Lukas et al., 2003; Lukas et al., 2004).
The current working model for the sensing and amplification of the DNA damage signal 
after DSBs included an amplification step mediated by MDC1, which recognizes initial 
γH2AX formation, recruits more MRN complex and thereby also more ATM (Stucki and 
Jackson, 2006). This mechanism culminates in the nuclear foci formation of many proteins 
involved in the DNA damage response. Surprisingly, we did not observe an obvious 
reduction of γH2AX foci formation in cells  with disrupted MDC1-MRN complex formation. 
This  indicates that the recruitment of ATM to DSB flanking chromatin regions is  not solely 
mediated by the NBS1 C-terminus. One possible alternative would be the proposed direct 
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recruitment of ATM via the FHA domain of MDC1 (Lou et al., 2006). Recent evidence 
suggested that MDC1 cooperates with ATM to generate high densities of γH2AX near the 
break. However, the spreading of the γH2AX signal along broken DNA strands was 
independent of MDC1 (Savic et al., 2009). Therefore, the refined model indicates that 
MDC1 is important in the establishment of a chromatin region around the DNA break where 
the equilibrium between phosphorylation and dephosphorylation is shifted towards the 
kinase activity by protecting γH2AX from phosphatase or chromatin remodeling activities. 
How the restriction to the damaged chromosome is achieved remains elusive. Moreover, 
accumulation and retention of the MRN complex by MDC1 does not seem to be required for 
G2/M checkpoint activation, not even in the presence of low numbers of breaks (chapter 5.2 
of this thesis). This indicates an additional role for MDC1-mediated accumulation of the 
MRN complex. Since the NBS1 FHA domain mutant showed a defect in G2/M checkpoint 
activation, one possibility could be that the FHA domain has additional binding partners that 
are essential for checkpoint activation. Another possibility could be the regulation of the 
intra-S phase checkpoint. It was  shown that MDC1 knockout MEFs reconstituted with a 
deletion mutant of MDC1 that lacks the SDT motifs responsible for MRN binding failed to 
rescue ionizing radiation-induced intra-S phase checkpoint (Wu et al., 2008). However, 
these results were in contradiction to a previous publication showing that accumulation of 
MDC1 on chromatin was not required for activation of intra-S phase checkpoint (Stucki et 
al., 2005). But it could still be that the direct interaction between MDC1 and the MRN 
complex is required for the activation of the intra-S phase checkpoint. The mechanism is 
not known until now. But it is most likely not related to NBS1 phosphorylation (which is 
essential for the intra-S phase checkpoint), because it was shown that NBS1 
phosphorylation is not compromised in MDC1-depleted cells (Goldberg et al., 2003; Stewart 
et al., 2003). In addition, another possible function of MDC1-mediated accumulation of 
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MRN may be related to DSB repair. Besides the described role in sensing and signaling of 
DSBs, the MRN complex seems to have another role in chromatin remodeling during DNA 
repair. The fact that deficiencies in various chromatin remodeling factors resulted in 
hypersensitivity to genotoxic agents highlighted the importance of this process during DNA 
repair via NHEJ and HR (Kouzarides, 2007). In yeast, it was shown that the MRX complex 
interacts with the chromatin remodeling complex RSC, and this interaction was necessary 
to recruit RSC to DSBs (Shim et al., 2005). Although there are no detailed mechanisms 
known how the MRN complex in mammalian cells  acts during chromatin remodeling, it is 
possible that the regulation is  similar to the one in yeast. Another aspect of MRN-mediated 
chromatin remodeling is  the regulation of TRRAP (transactivation transformation domain 
associated protein), a component of the Tip60 HAT complex. Depletion of TRRAP reduced 
histone acetylation, DNA repair via HR, and foci formation of DNA repair proteins such as 
RAD51, 53BP1, and BRCA1 (Murr et al., 2006). The MRN complex interacts with TRRAP in 
the absence of Tip60 and the resulting complex has no HAT activity. After dissociation of 
TRRAP from MRN, Tip60 could be recruited, which may lead to chromatin structure 
relaxation through its  HAT activity. Therefore, the complex formation between MDC1 and 
MRN and the MDC1-mediated accumulation of MRN at DSB flanking chromatin may be 
implicated in DNA damage-induced chromatin structure modulation. 
6.2 Dimerization of MDC1
6.2.1 Summary of own findings
We identified a highly conserved Thr residue at the very N-terminus of MDC1 (T4) that 
is  efficiently phosphorylated by purified ATM in vitro. By raising a phospho-specific antibody 
against the N-terminal region of MDC1 we were able to show that the T4 residue is a bona 
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fide ATM target site. Using phospho-peptide pull-down experiments, we showed that the 
phosphorylated MDC1 N-terminus specifically interacted with full-length MDC1 as well as 
with the MRN complex. Moreover, we could show a specific interaction of the 
phosphorylated MDC1 N-terminus  with the FHA domain of MDC1. This interaction was 
confirmed by isothermal titration calorimetry (ITC) and X-ray crystallography, revealing that 
the FHA domains of two MDC1 molecules associate in a head-to-tail orientation through a 
conserved hydrophobic patch. Since this interaction is strongly increased after 
phosphorylation of the T4 residue, DNA damage induces MDC1 dimerization through a 
specific interaction between its phosphorylated N-terminus and the FHA domain of a 
second MDC1 molecule. Using biochemical analysis and a life cell imaging approach, we 
could also show that DNA damage-induced MDC1 dimerization takes place in vivo.
6.2.2 Dimerization/multimerization of mediator proteins – a common theme?
Several other mediator/adaptor type proteins involved in the DNA damage response 
were found to form either homo- or heterodimers and multimers. This is true for 53BP1 in 
mammals, Crb2 in S.pombe, and RAD9p in S.cerevisiae. All three proteins contain a 
tandem Tudor domain, which in the case of 53BP1 and CRB2 has been shown to interact 
with methylated lysine residues in H3 or H4 (Huyen et al., 2004; Sanders et al., 2004), and 
is  required for the recruitment of the protein to sites  of DSBs. The C-terminus of all three 
proteins consists of a tandem BRCT domain. In RAD9p and Crb2, these BRCT domains 
were found to be important for dimerization of the protein (Du et al., 2004; Soulier and 
Lowndes, 1999). Moreover, the tandem BRCT domain of RAD9p and Crb2 interact with the 
phosphorylated H2A C-terminus (the yeast counterpart of the mammalian H2AX C-
terminus) (Hammet et al., 2007; Kilkenny et al., 2008). The crystal structure of the CRB2 
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BRCT tandem domain was  solved, and the biological role of this domain was analyzed in 
vivo by creating mutations that either disrupted dimerization or binding to phosphorylated 
H2A.1. Cells expressing a dimerization-defective CRB2 protein were shown to be defective 
for CRB2 recruitment to IRIFs and checkpoint activation, but had little effect on DNA repair. 
In contrast, a phospho-binding mutant of CRB2 showed normal recruitment to damaged 
DNA and an intact checkpoint response, but had defects in the DNA repair (Kilkenny et al., 
2008). For RAD9, the dimerization via the tandem BRCT domain was shown biochemically 
using GST pull-down assays as well as in a yeast-two-hybrid approach. In addition, it was 
shown that the interaction is DNA damage dependent, and that mutations  in the BRCT 
domain that abolished the protein homodimerization led to increased sensitivity of the cells 
to UV light and defects in checkpoint activation after DNA damage (Soulier and Lowndes, 
1999). Another study confirmed the DNA damage dependent RAD9 oligomerization 
proposing a molecular mechanism where the tandem BRCT domain interacts with the 
phosphorylated SCD domain. The RAD9 activation was unaffected by mutations that impair 
oligomerization, but it was required to sustain checkpoint signaling. In addition, RAD53-
mediated phosphorylation of RAD9 within its  BRCT domain attenuated the BRCT-SCD 
interaction providing a mechanism how the DNA damage response could be regulated 
(Usui et al., 2009). For 53BP1, the mammalian ortholog of the described checkpoint 
proteins in yeast, the requirements for efficient recruitment of the protein were recently 
resolved (Zgheib et al., 2009). These include the tandem tudor domain as described 
previously (Huyen et al., 2004; Sanders et al., 2004), as well as an independently folding 
oligomerization domain and a 15 amino acid C-terminal extension of the tudor domain. In 
addition, recruitment of 53BP1 to DSBs is dependent on MDC1 phosphorylation and 
subsequent recruitment of the ubiquitin ligases  RNF8 and RNF168, which leads to 
polyubiquitinylation of histones H2A and H2AX (Doil et al., 2009; Huen et al., 2007; Kolas  et 
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al., 2007; Mailand et al., 2007; Wang and Elledge, 2007). The oligomerization domain of 
53BP1 was essential for its efficient recruitment to sites of DSBs, since a protein lacking 
this region failed to accumulate in chromatin after IR (Zgheib et al., 2009).
In MDC1, the BRCT tandem domain and the FHA domain mediate binding to chromatin 
after DNA damage and protein dimerization, respectively. We could show that, in contrast to 
the yeast CRB2 and RAD9 proteins, the recruitment of MDC1 to damaged chromatin via its 
BRCT tandem domain was not affected by disrupting protein dimerization. Interestingly 
though, over-expression of the FHA domain exhibits a dominant negative effect on MDC1 
foci formation after IR (Goldberg et al., 2003). In addition, MDC1-FHA domain over 
expression interferes  with DSB repair and checkpoint activation (Dimitrova and de Lange, 
2006; Goldberg et al., 2003). The mechanism responsible for this dominant-negative effect 
remains elusive. 
In line of the DNA repair defect observed in the dimerization defective forms of CRB2 
and RAD9, it was shown that the FHA domain of MDC1 is essential for efficient DSB repair 
by HR (Xie et al., 2007; Zhang et al., 2005). A possible explanation for this  function is the 
proposed recruitment of ATM through the MDC1-FHA domain (Lou et al., 2006). So far, we 
were not able to assess the functional relevance of the MDC1 dimerization due to the lack 
of an efficient complementation system. By analyzing MDC1 mutants  that have a defect in 
dimerization but an otherwise intact FHA domain, it should be possible to dissect the 
functions of the MDC1 N-terminal region. It is likely that the dimerization of MDC1 plays an 
important role in some aspect of the mammalian DDR.
There are additional DDR proteins that homo- or hetero-dimerize. Another example is 
the hetero-dimerization of the tumor suppressor BRCA1 (breast cancer tumor suppressor 1) 
and its  binding partner BARD1 (BRCA1 associated RING domain 1). It was shown that a 
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complex between these two proteins forms an active E3 ubiquitin ligase (reviewed in 
(Starita and Parvin, 2006)). Therefore, dimerization in this case leads to a change in 
enzymatic activity. Since MDC1 has no known enzymatic activity, it is unlikely that MDC1 
dimerization has a comparable function to BRCA1/BARD1 dimerization.
TopBP1 is a protein required for the regulation of E2F1-mediated apoptosis. It was 
shown that Akt phosphorylates TopBP1 in vitro and in vivo. This phosphorylation mediates 
the oligomerization of the protein through its seventh and eighth BRCT domains, which in 
turn allows the interaction of TopBP1 with E2F1 and thereby represses its transcriptional 
activity (Liu et al., 2006). Similar to TopBP1, the oligomerization of microcephalin (MCPH1) 
also involves its BRCT domains. In addition, it was  shown that the interaction of MCPH1 
with the transcription factor E2F1 is  also dependent on protein oligomerization of 
microcephalin. In this case, the interaction regulated the expression of CHK1 and BRCA1, 
thereby regulating checkpoint activation, DNA repair, and apoptosis (Yang et al., 2008). 
These examples  highlight a possible theme of mediator protein di- or oligomerization in the 
DDR. 
Besides binding to its  own phosphorylated N-terminus, the MDC1 FHA domain has 
been reported to bind to some additional DDR proteins, namely CHK2, ATM and RAD51. 
So far it is not known if MDC1 dimerization is required for these interactions. Similar to 
MDC1, the oligomerization of CHK2 is mediated by phosphodependent interaction between 
a conserved Thr residue (Thr68) and its own FHA domain. This dimerization has  been 
reported to be important for CHK2 activation, signal amplification, and transduction in DNA 
damage checkpoint pathways (Xu et al., 2002). Moreover, this dimerization may modulate 
phosphodependent interactions  with effector proteins and substrates. In addition, a possible 
mechanism for the dissociation of the CHK2 dimer is  the autophosphorylation of the CHK2 
FHA domain at Ser140 (Li et al., 2008). It is still formally possible, that DNA damage-
Discussion
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induced MDC1 dimerization interferes with the binding of the MDC1 FHA domain to another 
protein, e.g. CHK2. This  interaction may be essential for the homo-oligomerization and 
activation of CHK2. However, MDC1 is  not essential for CHK2-mediated events in the DDR. 
Moreover, CHK2 is not recruited to DSB-flanking chromatin. Clearly, more work needs to be 
done to decipher the physiological role of MDC1 dimerization in the mammalian DDR.
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